|
  
|
CTD Chemicals (CC): Benzoates  
(show info)
Biomedical Ontology
Like Gene Ontology (GO), biomedical ontology such as phenotype ontology classifies and organizes gene-mutant/null phenotypic information from the very general at the top to more specific terms in the directed acyclic graph (DAG) by viewing an individual term as a node and its relations to parental terms (allowing for multiple parents) as directed edges. To navigate this hierarchy, we display all parental phenotypic terms to the current phenotypic term of interest ordered by their shortest distances to the current term. Also, only direct children phenotypic terms of the current phenotypic term are listed. Biomedical ontologies we have incorporated are as follows:
- Disease Ontology (DO) Ontology DO semantically integrates disease and medical vocabularies through extensive cross mapping of DO terms to MeSH, ICD, NCI’s thesaurus, SNOMED and OMIM.
- Human Phenotype (HP) Ontology HP captures phenotypic abnormalities that are described in OMIM, along with the corresponding disease-causing genes. It includes three complementary biological concepts: Mode_of_Inheritance (MI), ONset_and_clinical_course (ON), and Phenotypic_Abnormality (PA).
- Mouse Phenotype (MP) Ontology MP describes phenotypes of the mouse after a specific gene is genetically disrupted. Using it, Mouse Genome Informatics (MGI) provides high-coverate gene-level phenotypes for the mouse.
- Worm Phenotype (WP) Ontology WP classifies and organizes phenotype descriptions for C. elegans and other nematodes. Using it, WormBase provides primary resource for phenotype annotations for C. elegans.
- Yeast Phenotype (YP) Ontology Based on YP which is the major contributor to the ‘Ascomycete phenotype ontology’, Saccharomyces Genome Database (SGD) provides single mutant phenotypes for every gene in the yeast genome.
- Fly Phenotype (FP) Ontology FP refers to FlyBase controlled vocabulary. Specifically, a structured controlled vocabulary is used for the annotation of alleles (for their mutagen etc) in FlyBase.
- Fly Anatomy (FA) Ontology FA is a structured controlled vocabulary of the anatomy of Drosophila melanogaster, used for the description of phenotypes and where a gene is expressed.
- Zebrafish Anatomy (ZA) Ontology ZA displays anatomical terms of the zebrafish using standard anatomical nomenclature, together with affected genes.
- Xenopus Anatomy (XA) Ontology XA represents the lineage of tissues and the timing of development for frogs (Xenopus laevis and Xenopus tropicalis). It is used to annotate Xenopus gene expression patterns and mutant and morphant phenotypes.
- Arabidopsis Plant Ontology (AP) Ontology As a major contributor to Plant Ontology which describes plant anatomical and morphological structures (AN) and growth and developmental stages (DE), the Arabidopsis Information Resource (TAIR) provides arabidopsis plant ontology annotations for the model higher plant Arabidopsis thaliana.
- Enzyme Commission (EC) Ontology Each enzyme is allocated a four-digit EC number, the first three digits of which define the reaction catalysed and the fourth of which is a unique identifier (serial number). Each enzyme is also assigned a systematic name that uniquely defines the reaction catalysed.
- UniProtKB KeyWords (KW) Ontology Keywords in UniProtKB are controlled vocabulary, providing a summary of the entry content and are used to index UniProtKB/Swiss-Prot entries based on 10 categories (the category "Technical term" being excluded here). Each keyword is attributed manually to UniProtKB/Swiss-Prot entries and automatically to UniProtKB/TrEMBL entries (according to specific annotation rules).
- CTD Diseases (CD) Ontology CD is MEDIC disease vocabulary that is modified by CTD from the "Diseases" [C] branch of Medical Subject Headings (MeSH), combined with genetic disorders from the Online Mendelian Inheritance in OMIM database.
- CTD Chemicals (CC) Ontology CC is chemical vocabulary that is adapted by CTD from the "Chemicals and Drugs" category and Supplementary Concept Records of Medical Subject Headings (MeSH, a hierarchical vocabulary used to index articles for MEDLINE/PubMed).
Jump to [ Top · Hierarchy · Annotations ]
Root: CC Hierarchy (CTD chemicals from Comparative Toxicogenomics Database)
| Shortest distance to current term (+ for parents, - for children) |
CC term [CC ID] <#Children> |
#Domains (Superfamily|Family) |
#Supra-domain (Single|Duplex|Triple) |
| + + + + 4: | Hydrocarbons [MESH:D006838] <35> | (468|641) |
(485|436|221) |
| + + + + 4: | Chemicals [MESH:D] <13> |
| + + + 3: | Organic Chemicals [MESH:D009930] <621> | (617|829) |
(620|532|254) |
| + + + 3: | Hydrocarbons, Cyclic [MESH:D006844] <11> | (425|591) |
(443|416|217) |
| + + 2: | Hydrocarbons, Aromatic [MESH:D006841] <5> | (395|557) |
(413|388|204) |
| + + 2: | Carboxylic Acids [MESH:D002264] <282> | (390|539) |
(394|353|174) |
| + 1: | Benzene Derivatives [MESH:D001555] <291> | (258|358) |
(273|258|139) |
| + 1: | Acids, Carbocyclic [MESH:D000146] <9> | (129|172) |
(140|125|72) |
| 0: | Benzoates [MESH:D001565] <724> | (81|108) |
(89|80|52) |
| - 1: | Benzamides [MESH:D001549] <1111> | (42|49) |
(45|35|28) |
| - 1: | Hydroxybenzoates [MESH:D062385] <141> | (29|33) |
(30|19|12) |
| - 1: | Nitrobenzoates [MESH:D009579] <79> | (1|0) |
(1|0|0) |
| - 1: | Aminobenzoates [MESH:D062365] <71> | (17|19) |
(18|7|1) |
| - 1: | Chlorobenzoates [MESH:D002723] <61> | (14|15) |
(17|8|1) |
| - 1: | Iodobenzoates [MESH:D007463] <24> | (3|2) |
(3|0|0) |
| - 1: | Benzoyl Peroxide [MESH:D001585] <10> | (0|0) |
(0|0|0) |
| - 1: | Bromobenzoates [MESH:D001970] <9> | (2|2) |
(2|0|0) |
| - 1: | Benzoylcholine [MESH:D001588] <5> | (0|0) |
(0|0|0) |
| - 1: | Mercuribenzoates [MESH:D008626] <4> | (7|7) |
(9|5|1) |
| - 1: | Benzoic Acid [MESH:D019817] <1> | (2|1) |
(2|0|0) |
| - 1: | ((dimethylamino)methyl)acrylo-4-((benzoylsulfonyl)oxy)phenone [MESH:C111575] | (0|0) |
(0|0|0) |
| - 1: | ((dimethylamino)methyl)acrylo-4-((hydroxybenzoylsulfonyl)oxy)phenone [MESH:C111576] | (0|0) |
(0|0|0) |
| - 1: | (1)-2-((3,4)-3-Methyl-4-(N-phenyl-N-propionylamino)piperidin-1-yl)-1-phenylethyl p-bromobenzoate [MESH:C464681] | (0|0) |
(0|0|0) |
| - 1: | (1S)-1-phenylethanaminium 4-(((1S,2S)-1-hydroxy-2,3-dihydro-1H,1'H-(2,2'-biinden)-2-yl)methyl)benzoa [MESH:C576286] | (0|0) |
(0|0|0) |
| - 1: | (2S,3S)-2-methyl-3-((1S)-1-phenylethoxy)cyclopent-5-en-1-yl benzoate [MESH:C534899] | (0|0) |
(0|0|0) |
| - 1: | (3,10-dihydroxybenz(c)xanthene-7-yl)-4-carboxy-2-methylbenzene [MESH:C533355] | (0|0) |
(0|0|0) |
| - 1: | (3-((3-((diethoxymethyl)hydroxyphosphinyl)propyl)amino)methyl)benzoic acid [MESH:C105510] | (0|0) |
(0|0|0) |
| - 1: | (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid [MESH:C105509] | (0|0) |
(0|0|0) |
| - 1: | (4-(((4-(4-(2-chlorophenyl)-1-piperazinyl)-6-phenyl-2-pyrimidinyl)thio)methyl)-benzoic acid) [MESH:C000612188] | (0|0) |
(0|0|0) |
| - 1: | (E)-3-((((6-(2-carboxyethenyl)-5-((8-(4-methoxyphenyl)octyl)oxy)-2-pyridinyl)methyl)thio)methyl)benz [MESH:C083427] | (0|0) |
(0|0|0) |
| - 1: | (E)-methyl 2-((1,4-di-p-tosyl-1,2,3,4-tetrahydroquinoxalin-2-ylidene)methyl)benzoate [MESH:C523945] | (0|0) |
(0|0|0) |
| - 1: | (tetrahydro)pyrimidin-2-one-5-carboxylate [MESH:C530350] | (0|0) |
(0|0|0) |
| - 1: | (trifluoromethyl)phenyldiazirinylfenpyroximate [MESH:C472745] | (0|0) |
(0|0|0) |
| - 1: | 1,1-di-(3-carboxyphenyl)ethane [MESH:C492565] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-benzene-tricarbonyl trichloride [MESH:C424386] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5-tris(2'-(4'-benzoic acid)vinyl)benzene [MESH:C000601530] | (0|0) |
(0|0|0) |
| - 1: | 1,3-bis(3-deoxyglucopyranose-3-yloxy)-2-propyl-4-benzoylbenzoate [MESH:C076517] | (0|0) |
(0|0|0) |
| - 1: | 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole [MESH:C079393] | (0|0) |
(0|0|0) |
| - 1: | 1,4-bis(3-carboxy-4-hydroxyphenylethenyl)-benzene [MESH:C413183] | (0|0) |
(0|0|0) |
| - 1: | 1,6-hexanediol dibenzoate [MESH:C542277] | (0|0) |
(0|0|0) |
| - 1: | 1-(4-carboxyphenoxy)-10-(4-chlorophenoxy)decane [MESH:C036105] | (0|0) |
(0|0|0) |
| - 1: | 1-(4-carboxyphenyl)-3-methoxy-2,12,13-trioxatricyclo(7.2.2.0(4,9))tridecane [MESH:C435942] | (0|0) |
(0|0|0) |
| - 1: | 1-(5-(carboxyphenylthio)-2-thenylideneamino)hydantoin [MESH:C063961] | (0|0) |
(0|0|0) |
| - 1: | 1-(benzoyloxy)-2-cyclodecene-4,9-diyne-6,7,8-triol [MESH:C100561] | (0|0) |
(0|0|0) |
| - 1: | 1-(ethoxycarbonyl)pentyl 3,5-bis(acetylamino)-2,4,6-triiodobenzoate [MESH:C116058] | (0|0) |
(0|0|0) |
| - 1: | 1-O-(2-aminobenzoyl)-alpha-l-rhamnopyranoside [MESH:C000627824] | (0|0) |
(0|0|0) |
| - 1: | 1-benzoyl-2-(4-methylthio)benzoyloxyethene [MESH:C081836] | (0|0) |
(0|0|0) |
| - 1: | 1-benzoyl-2-trifluoromethyl-2-acetoxyethene [MESH:C081835] | (0|0) |
(0|0|0) |
| - 1: | 1-carboxy-3-methoxyphenyl 6-O-(4-(glucopyranosyloxy)vanilloyl)glucopyranoside [MESH:C525328] | (0|0) |
(0|0|0) |
| - 1: | 1-ethoxyvinyl benzoate [MESH:C419449] | (0|0) |
(0|0|0) |
| - 1: | 1-hydroxymaprounic 3-p-hydroxybenzoate [MESH:C087541] | (0|0) |
(0|0|0) |
| - 1: | 1-methyl-4-piperidyl 4'-fluorobenzoate [MESH:C102686] | (0|0) |
(0|0|0) |
| - 1: | 12-benzyloxy-4-(4-carboxyphenyl)-2,3,13-trioxatricyclo(7.2.2.0(1,7))tridecane [MESH:C465456] | (0|0) |
(0|0|0) |
| - 1: | 15-O-acetyl-3-O-benzoylcharaciol [MESH:C000608596] | (0|0) |
(0|0|0) |
| - 1: | 2'-O-methylperlatolic acid [MESH:C089055] | (0|0) |
(0|0|0) |
| - 1: | 2'-benzoyloxycinnamaldehyde [MESH:C484327] | (0|0) |
(0|0|0) |
| - 1: | 2,2',3-tribromophenyl-4,4'-dicarboxyilc acid [MESH:C543059] | (0|0) |
(0|0|0) |
| - 1: | 2,2'-dithiodibenzoic acid-1,3-di-4-pyridylpropane [MESH:C544587] | (0|0) |
(0|0|0) |
| - 1: | 2,2'-thiodibenzoic acid [MESH:C577134] | (0|0) |
(0|0|0) |
| - 1: | 2,2,4-trimethyl-2H-chromen-7-yl 4-(methoxycarbonyl)benzoate [MESH:C483202] | (0|0) |
(0|0|0) |
| - 1: | 2,2-dimethyl-5-nitroso-1,3-dioxan-5-yl benzoate [MESH:C522880] | (0|0) |
(0|0|0) |
| - 1: | 2,3,4,5-tetrafluorobenzoic acid [MESH:C000611771] | (0|0) |
(0|0|0) |
| - 1: | 2,3,4,5-tetramethoxybenzoyl chloride [MESH:C560290] | (0|0) |
(0|0|0) |
| - 1: | 2,3,4-trifluorobenzoic acid [MESH:C546553] | (0|0) |
(0|0|0) |
| - 1: | 2,3,5,6-tetrafluoro 2,3,4,5,6-pentafluorobenzoate [MESH:C107880] | (0|0) |
(0|0|0) |
| - 1: | 2,3,5,6-tetrafluoro-4-mercaptobenzoic acid disulfide [MESH:C507891] | (0|0) |
(0|0|0) |
| - 1: | 2,3,5,6-tetrafluoro-4-sulfanylbenzoic acid [MESH:C507890] | (0|0) |
(0|0|0) |
| - 1: | 2,3,5,6-tetrafluorobenzoic acid [MESH:C560614] | (0|0) |
(0|0|0) |
| - 1: | 2,3,6-trifluorobenzoic acid [MESH:C555784] | (0|0) |
(0|0|0) |
| - 1: | 2,3-dicyano-1,4-bis(3,4,5-tris(dodecyloxy)phenylcarbonyloxy)benzene [MESH:C522624] | (0|0) |
(0|0|0) |
| - 1: | 2,3-dimethylbenzoic acid [MESH:C086734] | (0|0) |
(0|0|0) |
| - 1: | 2,3-naphthalene-1,2,3,4-tetrahydro-2,3-bis(4-aminobenzoate) [MESH:C574186] | (0|0) |
(0|0|0) |
| - 1: | 2,3-naphthalene-1,2,3,4-tetrahydro-2,3-bis(4-bromo-3,5-dihydroxybenzoate) [MESH:C574185] | (0|0) |
(0|0|0) |
| - 1: | 2,4,6-trinitroanilino benzoic acid [MESH:C501686] | (0|0) |
(0|0|0) |
| - 1: | 2,4-bis(2-acetoxybenzamido)benzoic acid [MESH:C015589] | (0|0) |
(0|0|0) |
| - 1: | 2,4-bis(2-hydroxybenzamido)benzoic acid [MESH:C012784] | (0|0) |
(0|0|0) |
| - 1: | 2,4-dichloro-5-sulfamoylbenzoic acid [MESH:C519313] | (0|0) |
(0|0|0) |
| - 1: | 2,4-dimethylbenzoic acid [MESH:C028523] | (0|0) |
(0|0|0) |
| - 1: | 2,5-dimethylpyrrolylbenzoic acid [MESH:C000611121] | (0|0) |
(0|0|0) |
| - 1: | 2,6-difluorobenzoic acid [MESH:C077004] | (0|0) |
(0|0|0) |
| - 1: | 2-(((2-butyl-1-((4-carboxyphenyl)-methyl)-1H-imidazol-5-yl)methyl)amino)-4-azidobenzoic acid [MESH:C401385] | (0|0) |
(0|0|0) |
| - 1: | 2-((2-chloroethyl)methylamino)ethyl-4-ethoxybenzoate [MESH:C000423] | (0|0) |
(0|0|0) |
| - 1: | 2-((3-(3,5-dimethylpiperidin-1-yl)-6-oxo-6H-anthra(1,9-cd)isoxazol-5-yl)amino)benzoic acid [MESH:C571689] | (0|0) |
(0|0|0) |
| - 1: | 2-((E)-(8-hydroxyquinolin-5-yl)-diazenyl)-4,5-dimethoxybenzoic acid [MESH:C578117] | (0|0) |
(0|0|0) |
| - 1: | 2-((benzyloxy)methyl)-4-hydroxyphenyl-O-glucuronopyranosyl-1-6-glucopyranoside [MESH:C525283] | (0|0) |
(0|0|0) |
| - 1: | 2-(-glucopyranosyloxy)-benzyl 3-(-glucopyranosyloxy)-benzoate [MESH:C543799] | (0|0) |
(0|0|0) |
| - 1: | 2-(1-(phenylsulfonyl)ethyl)benzoic acid [MESH:C460377] | (0|0) |
(0|0|0) |
| - 1: | 2-(1-(phenylsulfonyl)propyl)benzoic acid [MESH:C460378] | (0|0) |
(0|0|0) |
| - 1: | 2-(1-adamantyl)ethyl 4-((2,5-dihydroxyphenyl)methylamino)benzoate [MESH:C557270] | (0|0) |
(0|0|0) |
| - 1: | 2-(1-hydroxypentyl)-benzoate [MESH:C511222] | (0|0) |
(0|0|0) |
| - 1: | 2-(1-oxo-1H-2,3-dihydroisoindol-2-yl)benzoic acid [MESH:C555985] | (0|0) |
(0|0|0) |
| - 1: | 2-(2',4'-dihydroxy-3',5'-diiodobenzoyl)benzoic acid [MESH:C513928] | (0|0) |
(0|0|0) |
| - 1: | 2-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate [MESH:C000619251] | (0|0) |
(0|0|0) |
| - 1: | 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol-2-hydroxybenzoic acid [MESH:C562181] | (0|0) |
(0|0|0) |
| - 1: | 2-(2-(2-(diethylamino)-2-oxoacetamido)propan-2-yl)-4-(4-fluorobenzylcarbamoyl)-1-methyl-6-oxo-1,6-di [MESH:C573637] | (0|0) |
(0|0|0) |
| - 1: | 2-(2-beta-L-arabinopyranosyloxy-beta-D-glucopyranosyloxy)-3(3-D-apiofuranosyloxy-beta-D-glucopyranos [MESH:C587740] | (0|0) |
(0|0|0) |
| - 1: | 2-(2-hydroxypropanamido)benzoic acid [MESH:C000594866] | (0|0) |
(0|0|0) |
| - 1: | 2-(2-thiophenecarboxy)benzoic acid [MESH:C074115] | (0|0) |
(0|0|0) |
| - 1: | 2-(3-(pyridin-2-ylmethoxy)pyrrolidin-1-yl)-5-(trifluoromethyl)benzoic acid [MESH:C000591624] | (0|0) |
(0|0|0) |
| - 1: | 2-(3-bromophenoxy)-4-(1-(3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl)hexyl)be [MESH:C577953] | (0|0) |
(0|0|0) |
| - 1: | 2-(3-bromophenoxy)-4-(3,3-dimethyl-1-((5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1-(2H)-yl)piperidin-1 [MESH:C577952] | (0|0) |
(0|0|0) |
| - 1: | 2-(3-ethylthioureido)benzoic acid [MESH:C000627299] | (0|0) |
(0|0|0) |
| - 1: | 2-(4-(6-cyclohexyloxy-2-naphthyloxy)phenylacetamide)benzoic acid [MESH:C416047] | (0|0) |
(0|0|0) |
| - 1: | 2-(4-(amino(N-cyclobutyl-N-methylcarbamoyl)methyl)cyclohexylmethoxymethyl)-5-methylbenzoic acid [MESH:C545654] | (0|0) |
(0|0|0) |
| - 1: | 2-(4-(nitrooxymethyl)benzamido)phenyl 4-(nitrooxymethyl)benzoate [MESH:C561758] | (0|0) |
(0|0|0) |
| - 1: | 2-(4-carboxyphenyl)-5,6-dimethylbenzimidazole [MESH:C080307] | (0|0) |
(0|0|0) |
| - 1: | 2-(4-chlorophenoxymethyl)benzoic acid [MESH:C529841] | (0|0) |
(0|0|0) |
| - 1: | 2-(4-fluorobenzoylamino)benzoic acid methyl ester [MESH:C568977] | (0|0) |
(0|0|0) |
| - 1: | 2-(5-ethoxycarbonyl-4-ethyl-6-(2-naphthyl)-1,2,3,6-tetrahydro-2-oxopyrimidin-1-yl)ethyl benzoate [MESH:C103917] | (0|0) |
(0|0|0) |
| - 1: | 2-(N,N-dimethylamino)ethyl-4-ethoxybenzoate [MESH:C011783] | (0|0) |
(0|0|0) |
| - 1: | 2-(N-phthalimidomethyl)benzoic acid [MESH:C408679] | (0|0) |
(0|0|0) |
| - 1: | 2-(acetoxymethyl)benzoic acid [MESH:C082521] | (0|0) |
(0|0|0) |
| - 1: | 2-(isopropylthio)benzoic acid [MESH:C121088] | (0|0) |
(0|0|0) |
| - 1: | 2-(pentafluorobenzyloxycarbonyl)benzoyl chloride [MESH:C555522] | (0|0) |
(0|0|0) |
| - 1: | 2-(trimethylsilyl)benzoic acid [MESH:C541624] | (0|0) |
(0|0|0) |
| - 1: | 2-O-p-hydroxybenzoyl-6-O-galloyl-alpha-4C1-glucopyranose [MESH:C521616] | (0|0) |
(0|0|0) |
| - 1: | 2-acetoxy-5-(2-4-(trifluoromethyl)phenethylamino)benzoic acid [MESH:C575483] | (0|0) |
(0|0|0) |
| - 1: | 2-acetoxymethylbenzoate [MESH:C444539] | (0|0) |
(0|0|0) |
| - 1: | 2-amino-3-(3'-aminopropoxy)benzoic acid [MESH:C000621552] | (0|0) |
(0|0|0) |
| - 1: | 2-amino-5-bromobenzoic acid [MESH:C571559] | (0|0) |
(0|0|0) |
| - 1: | 2-aminomethylbenzoic acid [MESH:C411503] | (0|0) |
(0|0|0) |
| - 1: | 2-benzylthio-5-trifluoromethylbenzoic acid [MESH:C006829] | (0|0) |
(0|0|0) |
| - 1: | 2-bromomethyl-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl [MESH:C413285] | (0|0) |
(0|0|0) |
| - 1: | 2-carboperoxy-3,4,5,6-tetrafluorobenzoic acid [MESH:C000604834] | (0|0) |
(0|0|0) |
| - 1: | 2-dimethylaminomethylcyclohexyl benzoate [MESH:C057721] | (0|0) |
(0|0|0) |
| - 1: | 2-ethylhexyl 2,3,4,5-tetrabromobenzoate [MESH:C576261] | (0|0) |
(0|0|0) |
| - 1: | 2-fluoro-4-(((8-bromo-2,2-dimethyl-4-(4-methylphenyl)chroman-6-yl)carbonyl)amino)benzoic acid [MESH:C584476] | (0|0) |
(0|0|0) |
| - 1: | 2-fluorobenzoic acid [MESH:C022894] | (0|0) |
(0|0|0) |
| - 1: | 2-hydroxy-3-methoxybenzoic acid [MESH:C000621631] | (0|0) |
(0|0|0) |
| - 1: | 2-hydroxy-3-methoxybenzoic acid glucose ester [MESH:C117314] | (0|0) |
(0|0|0) |
| - 1: | 2-hydroxy-4-methoxy benzoic acid [MESH:C112536] | (0|0) |
(0|0|0) |
| - 1: | 2-hydroxy-5-((E)-(4-nitrophenyl)diazenyl)benzoic acid [MESH:C000590038] | (0|0) |
(0|0|0) |
| - 1: | 2-hydroxy-p-toluic acid [MESH:C582189] | (0|0) |
(0|0|0) |
| - 1: | 2-hydroxymaprounic acid 2,3-bis(4-hydroxybenzoate) [MESH:C087542] | (0|0) |
(0|0|0) |
| - 1: | 2-methoxybenzoyl phosphate [MESH:C091890] | (0|0) |
(0|0|0) |
| - 1: | 2-methoxybenzyl benzoate [MESH:C507556] | (0|0) |
(0|0|0) |
| - 1: | 2-methyl-1-propenylbenzoate [MESH:C101261] | (0|0) |
(0|0|0) |
| - 1: | 2-methyl-3-hydroxy-4-carboxyphenylglycine [MESH:C469330] | (0|0) |
(0|0|0) |
| - 1: | 2-methyl-6-(3-(2-phenyloxazol-4-ylmethoxy)propoxymethyl)benzoic acid [MESH:C545089] | (0|0) |
(0|0|0) |
| - 1: | 2-pyrazolylbenzoic acid [MESH:C573961] | (0|0) |
(0|0|0) |
| - 1: | 2-selenobenzyl-1-benzoic acid [MESH:C481305] | (0|0) |
(0|0|0) |
| - 1: | 2-sulfamoylbenzoic acid [MESH:C028803] | (0|0) |
(0|0|0) |
| - 1: | 2-sulfobenzoic acid [MESH:C028805] | (0|0) |
(0|0|0) |
| - 1: | 2-sulfobenzoic acid cyclic anhydride [MESH:C028022] | (0|0) |
(0|0|0) |
| - 1: | 2-tetrahydropyranylbenzoate [MESH:C019105] | (0|0) |
(0|0|0) |
| - 1: | 2-thiosalicylic acid [MESH:C026196] | (0|0) |
(0|0|0) |
| - 1: | 2-toluic acid [MESH:C009502] | (0|0) |
(0|0|0) |
| - 1: | 2-toluic acid glucuronide [MESH:C026112] | (0|0) |
(0|0|0) |
| - 1: | 3'',3'''-dichloro-4'',4'''-bis(4-carboxybenzyloxy)-5'',5'''-dicarboxy-4',4'-diphenyl-3-(1-(3'-buteny [MESH:C119212] | (0|0) |
(0|0|0) |
| - 1: | 3',3''-dibromo-4',4''-dimethoxy-5',5''-bis(methoxycarbonyl)-1,1-diphenyl-1-heptene [MESH:C100922] | (0|0) |
(0|0|0) |
| - 1: | 3,29-dibenzoyl rarounitriol [MESH:C000604165] | (0|0) |
(0|0|0) |
| - 1: | 3,3'-(1,2,4,5-tetrazine-3,6-diyl)dibenzoic acid [MESH:C582762] | (0|0) |
(0|0|0) |
| - 1: | 3,4-dicarboxyphenylglycine [MESH:C110733] | (0|0) |
(0|0|0) |
| - 1: | 3,4-dihydroxy-3,4-dihydrobenzoic acid [MESH:C484573] | (0|0) |
(0|0|0) |
| - 1: | 3,4-dimethylbenzoic acid [MESH:C102831] | (0|0) |
(0|0|0) |
| - 1: | 3,4-methylenedioxybenzoic acid hydrazide [MESH:C004258] | (0|0) |
(0|0|0) |
| - 1: | 3,5-bis((bis(2-pyridylmethyl)amino)methyl)benzoic acid [MESH:C000623200] | (0|0) |
(0|0|0) |
| - 1: | 3,5-bis(3-methyl-but-2-enyl)-4-O-(beta-D-xylopyranosyl-(1-2)-beta-D-glucopyranosyl)benzoic acid [MESH:C584636] | (0|0) |
(0|0|0) |
| - 1: | 3,5-bis(chloromethyl)benzoic acid [MESH:C000622574] | (0|0) |
(0|0|0) |
| - 1: | 3,5-dicarboxyphenylglycine [MESH:C110735] | (0|0) |
(0|0|0) |
| - 1: | 3,5-dichloro-4-(4-chlorobenzoyl)benzoic acid [MESH:C104827] | (0|0) |
(0|0|0) |
| - 1: | 3,5-dimethoxy-2-(6-oxo-5-pentyl-6H-pyran-3-carbonyl)-benzoic acid [MESH:C512659] | (0|0) |
(0|0|0) |
| - 1: | 3,5-dimethoxy-4-hydroxy methyl benzoate [MESH:C580605] | (0|0) |
(0|0|0) |
| - 1: | 3,5-dimethylbenzoic acid [MESH:C094650] | (0|0) |
(0|0|0) |
| - 1: | 3,7-dimethyl-1,6-octadien-3-yl benzoate [MESH:C475594] | (0|0) |
(0|0|0) |
| - 1: | 3-((1-carboxy-4-mercaptobutyl)thio)benzoic acid [MESH:C510676] | (0|0) |
(0|0|0) |
| - 1: | 3-((3-((4-chlorophenyl)phenylmethylene)-2,3-dihydro-2-oxo-1H-indol-1-yl)methyl)benzoic acid [MESH:C000605627] | (0|0) |
(0|0|0) |
| - 1: | 3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone [MESH:C482900] | (0|0) |
(0|0|0) |
| - 1: | 3-((6-((5-benzylidene-3,6-dioxopiperazin-2-ylidene)methyl)pyridin-3-yloxy)methyl)benzoic acid [MESH:C586098] | (0|0) |
(0|0|0) |
| - 1: | 3-((6-(1-((3-methoxycarbonylphenyl)methyl)indol-6-yl)indol-1-yl)methyl)benzoic acid [MESH:C000591349] | (0|0) |
(0|0|0) |
| - 1: | 3-((N,N-dimethylaminophenyl)-4'-diazenyl)benzoic acid [MESH:C480780] | (0|0) |
(0|0|0) |
| - 1: | 3-(1-(3-cyclopropylmethoxy-4-difluoromethoxybenzyl)-1H-pyrazol-3-yl)benzoic acid [MESH:C575161] | (0|0) |
(0|0|0) |
| - 1: | 3-(1-carboxy-4-mercaptobutoxy)benzoic acid [MESH:C510675] | (0|0) |
(0|0|0) |
| - 1: | 3-(1-oxo-1H-2,3-dihydroisoindol-2-yl)benzoic acid [MESH:C555986] | (0|0) |
(0|0|0) |
| - 1: | 3-(2-benzyl-3-(propionylthio)propionyl)amino-5-methybenzoic acid [MESH:C110981] | (0|0) |
(0|0|0) |
| - 1: | 3-(2-benzyl-3-mercaptopropionyl) amino-5-methylbenzoic acid [MESH:C110982] | (0|0) |
(0|0|0) |
| - 1: | 3-(2-mercaptoethyl)biphenyl-2,3-dicarboxylic acid [MESH:C577642] | (0|0) |
(0|0|0) |
| - 1: | 3-(3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid [MESH:C582978] | (0|0) |
(0|0|0) |
| - 1: | 3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester [MESH:C569594] | (0|0) |
(0|0|0) |
| - 1: | 3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde [MESH:C069617] | (0|0) |
(0|0|0) |
| - 1: | 3-(4-hydroxy-3-methoxyphenyl)-2-oxopropyl benzoate [MESH:C511977] | (0|0) |
(0|0|0) |
| - 1: | 3-(4-octadecyl)benzoylacrylic acid [MESH:C069438] | (0|0) |
(0|0|0) |
| - 1: | 3-(5-(4-oxo-2-thioxo-3-(3-trifluoromethylphenyl)thiazolidin-5-ylidenemethyl)furan-2-yl)benzoic acid [MESH:C543994] | (0|0) |
(0|0|0) |
| - 1: | 3-(5-amino-7-hydroxy-(1,2,3)triazolo(4,5-d)pyrimidin-2-yl)benzoic acid [MESH:C484863] | (0|0) |
(0|0|0) |
| - 1: | 3-(bromomethyl)-2-chloro-4-(methylsulfonyl)-benzoic acid [MESH:C000632904] | (0|0) |
(0|0|0) |
| - 1: | 3-(hydroxy(tosyloxy)iodo)benzoic acid [MESH:C527339] | (0|0) |
(0|0|0) |
| - 1: | 3-acetamido-4-methyl benzoic acid [MESH:C000591486] | (0|0) |
(0|0|0) |
| - 1: | 3-amino-5-(1-(2-((4-(amino(imino)methyl)benzyl)amino)-2-oxoethyl)-5-(isopropylamino)-6-oxo-1,6-dihyd [MESH:C478621] | (0|0) |
(0|0|0) |
| - 1: | 3-azido-5-iodobenzyl fenpyroximate [MESH:C571740] | (0|0) |
(0|0|0) |
| - 1: | 3-carboxy-5-(2-tetradecylhexadecylaminocarbonyl)phenylthio fucopyranoside [MESH:C442392] | (0|0) |
(0|0|0) |
| - 1: | 3-cyclopropyl-4-(4-(2-(((6,6-dimethylbicyclo(3.1.1)heptan-2-yl)methyl)amino)-2-oxoethyl)piperidin-1- [MESH:C000589444] | (0|0) |
(0|0|0) |
| - 1: | 3-fluoro-2-(1-(1-naphthyl)ethyl)benzoic acid [MESH:C413376] | (0|0) |
(0|0|0) |
| - 1: | 3-fluorobenzoic acid [MESH:C022895] | (0|0) |
(0|0|0) |
| - 1: | 3-geranyl-4-hydroxy-5-(3'',3''-dimethylallyl)benzoic acid [MESH:C587411] | (0|0) |
(0|0|0) |
| - 1: | 3-geranyl-4-hydroxy-5-(3'-methyl-2'-butenyl)benzoic acid [MESH:C401930] | (0|0) |
(0|0|0) |
| - 1: | 3-iodobenzoyl-biocytin [MESH:C119845] | (0|0) |
(0|0|0) |
| - 1: | 3-methyl-4-(1H-pyrrol-1-yl)benzoic acid [MESH:C580805] | (0|0) |
(0|0|0) |
| - 1: | 3-phenoxybenzoic acid [MESH:C017618] | (2|2) |
(2|0|0) |
| - 1: | 3-thioanisoyl-1,2,2-trimethylcyclopentane-1-carboxylic acid [MESH:C085799] | (0|0) |
(0|0|0) |
| - 1: | 3-toluic acid [MESH:C009503] | (0|0) |
(0|0|0) |
| - 1: | 4'-((2,3-dimethyl-5-(pyridin-3-ylmethylcarbamoyl)-1H-indol-1-yl)methyl)biphenyl-2-carboxylic acid [MESH:C000594850] | (0|0) |
(0|0|0) |
| - 1: | 4'-(1-(((6,7-dichloro-3- oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)acetyl)(methyl)amino)-2-(4-morpholin [MESH:C554432] | (0|0) |
(0|0|0) |
| - 1: | 4'-acetamidophenyl 4-guanidinobenzoate [MESH:C058095] | (0|0) |
(0|0|0) |
| - 1: | 4'-carbomethoxyphenyl 4-guanidinobenzoate [MESH:C058096] | (0|0) |
(0|0|0) |
| - 1: | 4'-carboxyphenyl 4-guanidinobenzoate [MESH:C058197] | (0|0) |
(0|0|0) |
| - 1: | 4'-octyl-4-biphenylcarboxylic acid [MESH:C507710] | (0|0) |
(0|0|0) |
| - 1: | 4(4-(5-nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl)-benzoic acid ethyl ester [MESH:C523934] | (0|0) |
(0|0|0) |
| - 1: | 4,4',6,6'-tetramethylbiphenyl-2,2'-dicarboxylic acid [MESH:C118402] | (0|0) |
(0|0|0) |
| - 1: | 4,4'-(2,5-dimethoxy-1,4-phenylene)bis(ethyne-2,1-diyl)dibenzoic acid [MESH:C575102] | (0|0) |
(0|0|0) |
| - 1: | 4,4'-dihydroxy-3,3'-imino-di-benzoic acid [MESH:C574059] | (0|0) |
(0|0|0) |
| - 1: | 4,4'-dimethylbiphenyl-2,2'-dicarboxylic acid [MESH:C118046] | (0|0) |
(0|0|0) |
| - 1: | 4,4'-dithiodibenzoic acid [MESH:C543486] | (0|0) |
(0|0|0) |
| - 1: | 4,4'-hydrazobenzenedicarboxylic acid [MESH:C103215] | (0|0) |
(0|0|0) |
| - 1: | 4,4'-oxydibenzoic acid [MESH:C539796] | (0|0) |
(0|0|0) |
| - 1: | 4,6-di-O-acetyl-2-O-tosyl-myo-inositol 1,3,5-orthobenzoate [MESH:C542997] | (0|0) |
(0|0|0) |
| - 1: | 4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amin [MESH:C528797] | (0|0) |
(0|0|0) |
| - 1: | 4-(((6-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)-2-(trifluoromethyl)-3-pyridinyl) [MESH:C000598201] | (0|0) |
(0|0|0) |
| - 1: | 4-(((8-bromo-2,2-dimethyl-4-(4-methylphenyl)chroman-6-yl)carbonyl)amino)benzoic acid [MESH:C584477] | (0|0) |
(0|0|0) |
| - 1: | 4-((1,1-dioxo-1,2-benzothiazol-3-yl)sulfanyl)benzoic acid [MESH:C577329] | (0|0) |
(0|0|0) |
| - 1: | 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid [MESH:C074011] | (0|0) |
(0|0|0) |
| - 1: | 4-((2-chloroethyl) (2-mesyloxyethyl)amino)benzoic acid [MESH:C092575] | (0|0) |
(0|0|0) |
| - 1: | 4-((3,5,5,8,8-pentamethyl--5,6,7,8-tetrahydro-2-naphthyl)carbonyl)benzoic acid O-methyloxime [MESH:C117667] | (0|0) |
(0|0|0) |
| - 1: | 4-((3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)carbonyl)benzoic acid oxime [MESH:C117666] | (0|0) |
(0|0|0) |
| - 1: | 4-((3,5-dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid [MESH:C000621246] | (0|0) |
(0|0|0) |
| - 1: | 4-((3-amino-2-naphthyl)aminomethyl)benzoic acid [MESH:C110816] | (0|0) |
(0|0|0) |
| - 1: | 4-((4-((4-oxo-2-thioxo-3-(o-tolyl)thiazolidin-5-ylidene)methyl)phenoxy)methyl)benzoic acid [MESH:C000611537] | (0|0) |
(0|0|0) |
| - 1: | 4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid [MESH:C121616] | (2|2) |
(2|0|0) |
| - 1: | 4-((5-(4-benzyloxybenzylidene)-2-(4-trifluoromethylphenylimino)-4-oxo-3-thiazolidinyl)methyl)benzoic [MESH:C573634] | (0|0) |
(0|0|0) |
| - 1: | 4-((5-bromo-4-((2,4-dioxo-3-(2-oxo-2-phenylethyl)-1,3-thiazolidin-5-ylidene)methyl)-2-ethoxyphenoxy) [MESH:C531217] | (0|0) |
(0|0|0) |
| - 1: | 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo(6.6.6)icosane-1-ylamino)methyl)benzoic acid [MESH:C543149] | (0|0) |
(0|0|0) |
| - 1: | 4-((deca-B-methyl-1,12-dicarba-closo-dodecaboran-1-yl)carbamoyl)benzoic acid [MESH:C416355] | (0|0) |
(0|0|0) |
| - 1: | 4-((fluoren-9-ylidenehydrazinylidene)methyl)benzoic acid [MESH:C000595660] | (0|0) |
(0|0|0) |
| - 1: | 4-(1,4,8,11-tetraazacyclotetradec-1-yl)methylbenzoic acid [MESH:C105391] | (0|0) |
(0|0|0) |
| - 1: | 4-(1-((bis(4-methylphenyl)methyl)carbamoyl)-3-(2-ethoxybenzyl)-4-oxoazetidine-2-yloxy)benzoic acid [MESH:C439760] | (0|0) |
(0|0|0) |
| - 1: | 4-(1-(3-chloro-4-(N'-(5-fluoro-2-methylphenyl)ureido)phenylacetyl)-(4S)-fluoro-(2S)-pyrrolidinylmeth [MESH:C534076] | (0|0) |
(0|0|0) |
| - 1: | 4-(1-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperidin-4-ylamino)benzoic acid [MESH:C401390] | (0|0) |
(0|0|0) |
| - 1: | 4-(1-acetyl-4-((4-chlorophenyl)amino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid [MESH:C000593790] | (0|0) |
(0|0|0) |
| - 1: | 4-(1-carboxyethyl)benozic acid [MESH:C092899] | (0|0) |
(0|0|0) |
| - 1: | 4-(1-oxo-1H-2,3-dihydroisoindol-2-yl)benzoic acid [MESH:C555987] | (0|0) |
(0|0|0) |
| - 1: | 4-(2'R,4'-dihydroxybutoxy)benzoic acid [MESH:C000625273] | (0|0) |
(0|0|0) |
| - 1: | 4-(2,2':6',2''-terpyridine)-4'-ylbenzoic acid [MESH:C000629421] | (0|0) |
(0|0|0) |
| - 1: | 4-(2,2-dimethyl-1--oxopropyl)benzoic acid 1,2,4-butanetriyl ester [MESH:C421622] | (0|0) |
(0|0|0) |
| - 1: | 4-(2,2-dimethyl-1-hydroxypropyl)benzoic acid [MESH:C116992] | (0|0) |
(0|0|0) |
| - 1: | 4-(2,2-dimethyl-1-oxopropyl)benzoic acid [MESH:C116991] | (0|0) |
(0|0|0) |
| - 1: | 4-(2,2-dimethyl-4-(tol-4-yl)benzochrom-3-en-7-yl)benzoic acid [MESH:C121652] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-((6-fluoro-2-((((3-(methyloxy)phenyl)methyl)amino)carbonyl)-4-oxo-3,4-dihydroquinazolin-5-yl)ox [MESH:C000595646] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benz [MESH:C000598200] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-(3,5,5,8,8-pentamethyl-5,8-disila-5,6,7,8-tetrahydro-2-naphthalenyl)-1-propenyl)benzoic acid [MESH:C525648] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-(4-isopropylbenzamido)ethoxy)benzoic acid [MESH:C058271] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-(5,5,8,8-tetramethyl-5,8-disila-5,6,7,8-tetrahydro-2-naphthalenyl)-1-propenyl)benzoic acid [MESH:C525647] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-(5,6,7,8--tetrahydro-5,5,8,8-tetramethylquinoxalyl)carboxamido)benzoic acid [MESH:C113648] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-propenyl)benzoic acid [MESH:C525646] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid [MESH:C038864] | (4|3) |
(4|2|0) |
| - 1: | 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid [MESH:C542472] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenyl 4-methylbenzoate [MESH:C000598277] | (0|0) |
(0|0|0) |
| - 1: | 4-(2-amino-3-((1-(2-benzo(b)thiophen-3-yl)-1-(benzylcarbamoyl)ethylcarbamoyl-2-(biphenyl-4-yl)ethylc [MESH:C478620] | (0|0) |
(0|0|0) |
| - 1: | 4-(3,4,5-trimethoxyphenoxy)benzoic acid [MESH:C000593723] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-(3, 5-di-t-4-methoxyphenyl)-3-oxo-1-propenyl)benzoic acid [MESH:C442165] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-(3,5-bis(trimethylsilyl)phenyl)-3-oxo-1-propenyl)benzoic acid [MESH:C063794] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl)benzoic acid [MESH:C415643] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-(5-(1H-indol-2-yl)-2,4-dimethoxyphenyl)acryloyl)benzoic acid [MESH:C519102] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-(5-chloro-2-(2-(((2,6-dimethylbenzyl)sulfonyl)amino)ethyl)-1-(diphenylmethyl)-1H-indol-3-yl)pro [MESH:C531069] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-(acryloyloxy)-2-hydroxypropoxy)phenyl 4-(3-(acryloyloxy)-2-hydroxypropoxy)benzoate [MESH:C000595729] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-acetyl-5-(acetylamino)-2-methyl-2,3-dihydro-1,3,4-thiadiazole-2-yl)phenyl benzoate [MESH:C000628731] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-amino-2-oxoazetidinonyl-1)methylbenzoic acid [MESH:C067209] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-benzyl-4-(5-(2-fluorophenyl)-ruan-2-ylmethylene)-5-oxo-4,5-dihydropyrazol-1-yl)benzoic acid [MESH:C527646] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-methyl-5-(2',6',6'-trimethyl-1'-cyclohex-1'-yl)pentadienamido)benzoic acid [MESH:C113649] | (0|0) |
(0|0|0) |
| - 1: | 4-(4'-azophenylazo)benzoate [MESH:C049265] | (0|0) |
(0|0|0) |
| - 1: | 4-(4,4,8-trimethyl-7-oxo-3-oxabicyclo(3.3.1)non-2-yl)benzoic acid methyl ester [MESH:C000610408] | (0|0) |
(0|0|0) |
| - 1: | 4-(4,5-diphenyl-1H-imidazol-2-yl)benzoyl chloride [MESH:C114684] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-((1-butyl-3-(cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undec-9-yl)methyl)pheno [MESH:C561761] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-((4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic ac [MESH:C509076] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-(2-(n-butoxy)ethoxy)-5-methylthiazol-2-yl)-2-fluorobenzoic acid [MESH:C507711] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl)benzoic acid [MESH:C000589241] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-(2-propyl-1,2-dicarba-closo-dodecaboran-l-yl)phenylamino)benzoic acid [MESH:C444859] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-(3,4-diethoxyphenyl)-1oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl)benzoic acid [MESH:C458040] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid [MESH:C572961] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid [MESH:C524106] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)benzoic acid [MESH:C583126] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-(4-dimethylaminophenyl)-5-phenyl-1H-imidazol-2-yl)benzoic acid methyl ester [MESH:C584462] | (0|0) |
(0|0|0) |
| - 1: | 4-(4-methoxy-3-(5-phenylpentoxy)phenyl)-2-methylbenzoic acid [MESH:C097772] | (0|0) |
(0|0|0) |
| - 1: | 4-(5-(7-fluoro-4-(trifluoromethyl)benzo(b)furan-2-yl)-1H-2-pyrrolyl)benzoic acid [MESH:C498503] | (0|0) |
(0|0|0) |
| - 1: | 4-(6-amino-5-hydroxybenzothiazol-2-yl)benzoic acid [MESH:C519051] | (0|0) |
(0|0|0) |
| - 1: | 4-(6-hydroxy-7-tricyclo(3.3.1.13,7)dec-1-yl-2-naphthalenyl)benzoic acid [MESH:C000591478] | (0|0) |
(0|0|0) |
| - 1: | 4-(8-((2-cyclopropyl-5-ethoxy-4-methylphenyl)methyl)-2-oxo-1,3,8-triazaspiro(4.5)decan-3-yl)benzoic [MESH:C000625369] | (0|0) |
(0|0|0) |
| - 1: | 4-(8-(3-nitrophenyl)-(1,7)naphthyridin-6-yl)benzoic acid [MESH:C405045] | (0|0) |
(0|0|0) |
| - 1: | 4-(8-benzo(1,2,5)oxadiazol-5-yl-(1,7)naphthyridine-6-yl)-benzoic acid [MESH:C449669] | (0|0) |
(0|0|0) |
| - 1: | 4-(N-methyl-N-(4-(trifluoromethyl)phenyl)sulfamoyl) benzoic acid [MESH:C000626785] | (0|0) |
(0|0|0) |
| - 1: | 4-(bromomethyl)benzoic acid [MESH:C529847] | (0|0) |
(0|0|0) |
| - 1: | 4-(bromomethyl)benzoylformate [MESH:C057515] | (0|0) |
(0|0|0) |
| - 1: | 4-(chloromethyl)benzoylformate [MESH:C057516] | (0|0) |
(0|0|0) |
| - 1: | 4-(dodecyloxy)benzoic acid 4-(((4-(dimethylamino)phenyl)imino)methyl)phenyl ester [MESH:C521245] | (0|0) |
(0|0|0) |
| - 1: | 4-(fluoromethyl)benzoylformate [MESH:C057517] | (0|0) |
(0|0|0) |
| - 1: | 4-(fluorosulfonyl)benzoic acid [MESH:C084636] | (0|0) |
(0|0|0) |
| - 1: | 4-(pyrazine-2-carboxamido)benzoic acid [MESH:C000605390] | (0|0) |
(0|0|0) |
| - 1: | 4-(trifluorovinyloxy)benzoyl chloride [MESH:C488678] | (0|0) |
(0|0|0) |
| - 1: | 4-O-beta-D-glucopyranosylbenzyl-benzoate [MESH:C000611769] | (0|0) |
(0|0|0) |
| - 1: | 4-acetylbenzoic acid [MESH:C115900] | (0|0) |
(0|0|0) |
| - 1: | 4-amidino-2-nitrophenyl 4'-anisate [MESH:C051327] | (0|0) |
(0|0|0) |
| - 1: | 4-azidobenzoyl chloride [MESH:C022786] | (0|0) |
(0|0|0) |
| - 1: | 4-azidophenyl fenpyroximate [MESH:C571739] | (0|0) |
(0|0|0) |
| - 1: | 4-azidotetrafluorobenzoic acid [MESH:C110129] | (0|0) |
(0|0|0) |
| - 1: | 4-benzyloxybenzoic acid [MESH:C015619] | (0|0) |
(0|0|0) |
| - 1: | 4-carboxybenzylideneaniline [MESH:C553727] | (0|0) |
(0|0|0) |
| - 1: | 4-carboxybiphenyl ether [MESH:C065921] | (0|0) |
(0|0|0) |
| - 1: | 4-carboxyphenylglycine [MESH:C079693] | (0|0) |
(0|0|0) |
| - 1: | 4-cyanobenzoic acid [MESH:C097383] | (0|0) |
(0|0|0) |
| - 1: | 4-diethylaminoethylbenzoate [MESH:C117781] | (0|0) |
(0|0|0) |
| - 1: | 4-ethoxybenzoic acid 2-(isopropylamino)ethyl ester [MESH:C057729] | (0|0) |
(0|0|0) |
| - 1: | 4-ethylbenzoic acid [MESH:C051230] | (0|0) |
(0|0|0) |
| - 1: | 4-fluorobenzoic acid [MESH:C022893] | (0|0) |
(0|0|0) |
| - 1: | 4-guanidinobenzoate [MESH:C023856] | (0|0) |
(0|0|0) |
| - 1: | 4-guanidinophenyl 4-guanidinobenzoate [MESH:C574627] | (0|0) |
(0|0|0) |
| - 1: | 4-hexyloxybenzoic acid [MESH:C576436] | (0|0) |
(0|0|0) |
| - 1: | 4-hydrazinobenzoic acid [MESH:C053198] | (0|0) |
(0|0|0) |
| - 1: | 4-hydrobenzoic acid [MESH:C000618574] | (0|0) |
(0|0|0) |
| - 1: | 4-isothiocyanatobenzoic acid [MESH:C035320] | (0|0) |
(0|0|0) |
| - 1: | 4-mercaptobenzoate [MESH:C013594] | (0|0) |
(0|0|0) |
| - 1: | 4-methylbenzyl 4'-(4-(guanidinomethyl)cyclohexylcarbonyloxy)biphenyl-4-carboxylate [MESH:C510407] | (0|0) |
(0|0|0) |
| - 1: | 4-methylimidazolium 2-((2-carboxyphenyl)disulfanyl)benzoate [MESH:C544580] | (0|0) |
(0|0|0) |
| - 1: | 4-methylthiobenzoic acid [MESH:C104409] | (0|0) |
(0|0|0) |
| - 1: | 4-nitrophenyl 4'-guanidinobenzoate [MESH:C002238] | (0|0) |
(0|0|0) |
| - 1: | 4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en [MESH:C111068] | (0|0) |
(0|0|0) |
| - 1: | 4-phenylazobenzoyl chloride [MESH:C015432] | (0|0) |
(0|0|0) |
| - 1: | 4-sulfobenzoic acid [MESH:C028804] | (0|0) |
(0|0|0) |
| - 1: | 4-tert-butylbenzoic acid [MESH:C034290] | (0|0) |
(0|0|0) |
| - 1: | 4-toluic acid [MESH:C009504] | (0|0) |
(0|0|0) |
| - 1: | 5-((6-chloro-5-(1-methylindol-5-yl)-1H-benzimidazol-2-yl)oxy)-2-methylbenzoic acid [MESH:C000620824] | (0|0) |
(0|0|0) |
| - 1: | 5-(2-(4-(3,4-difluorophenoxy)phenyl)ethylsulfamoyl)-2-methyl-benzoic acid [MESH:C546071] | (0|0) |
(0|0|0) |
| - 1: | 5-(3-(4-(octadecyloxy)phenyl)propionylamino)-2,4'-oxydibenzoic acid [MESH:C487873] | (0|0) |
(0|0|0) |
| - 1: | 5-(4-bromo-1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-2-chloro-4-fluorobenzoic acid isopropyl est [MESH:C415146] | (0|0) |
(0|0|0) |
| - 1: | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid [MESH:C000588958] | (2|1) |
(2|0|0) |
| - 1: | 5-fluorofarnesylthiosalicylic acid [MESH:C553900] | (0|0) |
(0|0|0) |
| - 1: | 5-hydroxy-2-(2-(4-hydroxyphenyl) acetyl)-3-methoxylbenzoic acid [MESH:C561954] | (0|0) |
(0|0|0) |
| - 1: | 6,13-diacetoxy-1,8,9-tribenzoyloxy-beta-dihydroagarofuran [MESH:C479090] | (0|0) |
(0|0|0) |
| - 1: | 6,8-dichloro-9,9-dimethyl-7-oxo-7,9-dihydroacridin-2-yl benzoate [MESH:C000626990] | (0|0) |
(0|0|0) |
| - 1: | 6-(N,N-dimethylamino)-5-phenylbicyclo(2.2.2)oct-2-yl benzoate [MESH:C401325] | (0|0) |
(0|0|0) |
| - 1: | 6alpha,7alpha-dihydroxy-beta-himachalene [MESH:C504096] | (0|0) |
(0|0|0) |
| - 1: | 7-(3-((4-hydroxyphenyl)butyl) glucopyranosid-O-6-yl) 4-O-glucopyranosylvanillin [MESH:C527900] | (0|0) |
(0|0|0) |
| - 1: | 7-(acetyloxy)-5a-((acetyloxy)methyl)octahydro-6-hydroxy- 2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepi [MESH:C000597848] | (0|0) |
(0|0|0) |
| - 1: | 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate [MESH:C519013] | (0|0) |
(0|0|0) |
| - 1: | 99mTc-MAMA-chrysamine G [MESH:C402414] | (0|0) |
(0|0|0) |
| - 1: | A112 tamibarotene dimethylaminoethyl ester [MESH:C572378] | (0|0) |
(0|0|0) |
| - 1: | AAT-008 [MESH:C000621941] | (0|0) |
(0|0|0) |
| - 1: | AGN 190121 [MESH:C104327] | (0|0) |
(0|0|0) |
| - 1: | AGN 190205 [MESH:C404934] | (0|0) |
(0|0|0) |
| - 1: | AGN 190521 [MESH:C404935] | (0|0) |
(0|0|0) |
| - 1: | AHR 13268D [MESH:C068205] | (0|0) |
(0|0|0) |
| - 1: | AP22161 [MESH:C409524] | (0|0) |
(0|0|0) |
| - 1: | AST-003 [MESH:C000608436] | (0|0) |
(0|0|0) |
| - 1: | AZD9977 [MESH:C000627339] | (0|0) |
(0|0|0) |
| - 1: | Am 580 [MESH:C068073] | (0|0) |
(0|1|0) |
| - 1: | BAY 58-2667 [MESH:C480588] | (0|0) |
(0|0|0) |
| - 1: | BCX 140 [MESH:C112527] | (0|0) |
(0|0|0) |
| - 1: | BMS 593214 [MESH:C553827] | (0|0) |
(0|0|0) |
| - 1: | BMS411 [MESH:C000622229] | (0|0) |
(0|0|0) |
| - 1: | BRL 1364 [MESH:C018178] | (0|0) |
(0|0|0) |
| - 1: | C646 compound [MESH:C584509] | (1|1) |
(1|0|0) |
| - 1: | CBS 211 A [MESH:C062800] | (0|0) |
(0|0|0) |
| - 1: | CC34301 [MESH:C000622584] | (0|0) |
(0|0|0) |
| - 1: | CC41801 [MESH:C000622583] | (0|0) |
(0|0|0) |
| - 1: | CD 2394 [MESH:C415025] | (0|0) |
(0|0|0) |
| - 1: | CD 2409 [MESH:C403177] | (0|0) |
(0|0|0) |
| - 1: | CD 2624 [MESH:C111955] | (0|0) |
(0|0|0) |
| - 1: | CD2665 [MESH:C000597561] | (0|0) |
(0|0|0) |
| - 1: | CGP 57250A [MESH:C102658] | (0|0) |
(0|0|0) |
| - 1: | CGP 62349 [MESH:C114540] | (0|0) |
(0|0|0) |
| - 1: | CGP 64213 [MESH:C104981] | (0|0) |
(0|0|0) |
| - 1: | CGP 67780 [MESH:C417906] | (0|0) |
(0|0|0) |
| - 1: | CGP 71982 [MESH:C114539] | (0|0) |
(0|0|0) |
| - 1: | CIN-102 [MESH:C000610527] | (0|0) |
(0|0|0) |
| - 1: | CJ 21164 [MESH:C455259] | (0|0) |
(0|0|0) |
| - 1: | CX09040 [MESH:C000604404] | (0|0) |
(0|0|0) |
| - 1: | Ch 55G [MESH:C063795] | (0|0) |
(0|0|0) |
| - 1: | Ch 80 [MESH:C098137] | (0|0) |
(0|0|0) |
| - 1: | Deferasirox [MESH:D000077588] | (0|0) |
(0|0|0) |
| - 1: | EB 2345 [MESH:C461879] | (0|0) |
(0|0|0) |
| - 1: | EC19 compound [MESH:C542238] | (0|0) |
(0|0|0) |
| - 1: | EC23 compound [MESH:C542239] | (0|0) |
(0|0|0) |
| - 1: | ER 34617 [MESH:C404926] | (0|0) |
(0|0|0) |
| - 1: | EiK1 compound [MESH:C576164] | (0|0) |
(0|0|0) |
| - 1: | FK 706 [MESH:C109799] | (1|0) |
(1|0|0) |
| - 1: | FL-70 [MESH:C006238] | (0|0) |
(0|0|0) |
| - 1: | Fluoro-Red [MESH:C104022] | (0|0) |
(0|0|0) |
| - 1: | GFA 116 [MESH:C488093] | (0|0) |
(0|0|0) |
| - 1: | GSK 650394 [MESH:C532254] | (0|0) |
(0|0|0) |
| - 1: | GSK2879552 [MESH:C000602008] | (0|0) |
(0|0|0) |
| - 1: | GW 3965 [MESH:C473027] | (1|1) |
(1|0|0) |
| - 1: | GW1100 [MESH:C515631] | (0|0) |
(0|0|0) |
| - 1: | Gluma AC-Bond [MESH:C455466] | (0|0) |
(0|0|0) |
| - 1: | HL 752 [MESH:C108655] | (0|0) |
(0|0|0) |
| - 1: | HX 630 [MESH:C422175] | (1|0) |
(1|0|0) |
| - 1: | HZL 7 compound [MESH:C529083] | (0|0) |
(0|0|0) |
| - 1: | IMB5046 [MESH:C000627176] | (0|0) |
(0|0|0) |
| - 1: | IR825 dye [MESH:C000601126] | (0|0) |
(0|0|0) |
| - 1: | Ilicicolinic acid C [MESH:C000596049] | (0|0) |
(0|0|0) |
| - 1: | Ilicicolinic acid D [MESH:C000596050] | (0|0) |
(0|0|0) |
| - 1: | JTT 305 [MESH:C568849] | (0|0) |
(0|0|0) |
| - 1: | KC 18 [MESH:C010399] | (0|0) |
(0|0|0) |
| - 1: | KP-496 [MESH:C528276] | (0|0) |
(0|0|0) |
| - 1: | KT203 [MESH:C000629986] | (0|0) |
(0|0|0) |
| - 1: | Kinzalkomb [MESH:C482401] | (0|0) |
(0|0|0) |
| - 1: | L 644698 [MESH:C112355] | (0|0) |
(0|0|0) |
| - 1: | LE 511 [MESH:C119609] | (0|0) |
(0|0|0) |
| - 1: | LF 7-0156 [MESH:C090248] | (0|0) |
(0|0|0) |
| - 1: | LG 100153 [MESH:C116984] | (0|0) |
(0|0|0) |
| - 1: | LG 100641 [MESH:C417528] | (0|0) |
(0|0|0) |
| - 1: | LX009 [MESH:C000627300] | (0|0) |
(0|0|0) |
| - 1: | LY 293111 [MESH:C094099] | (0|0) |
(0|0|0) |
| - 1: | LY 312340 [MESH:C471184] | (0|0) |
(0|0|0) |
| - 1: | LY2300559 [MESH:C000603976] | (0|0) |
(0|0|0) |
| - 1: | M-1960 [MESH:C019213] | (0|0) |
(0|0|0) |
| - 1: | MF-482 [MESH:C000607041] | (0|0) |
(0|0|0) |
| - 1: | MV026630 [MESH:C485023] | (0|0) |
(0|0|0) |
| - 1: | Methyl 2-((succinimidooxy)carbonyl)benzoate [MESH:C467959] | (0|0) |
(0|0|0) |
| - 1: | N',N'-dibenzylbenzohydrazide [MESH:C067745] | (0|0) |
(0|0|0) |
| - 1: | N-(2-benzoyloxyethyl)hexyldimethylammonium [MESH:C086051] | (0|0) |
(0|0|0) |
| - 1: | N-(2-carboxybenzoyl)leucine [MESH:C520631] | (0|0) |
(0|0|0) |
| - 1: | N-(dicyclohexyl)acetylpiperidine-4-(2-fluorobenzylidene-4-carboxylic acid) [MESH:C463492] | (0|0) |
(0|0|0) |
| - 1: | N-(dicyclohexyl)acetylpiperidine-4-benzylidene-4-carboxylic acid [MESH:C488696] | (0|0) |
(0|0|0) |
| - 1: | N-4-chlorobenzoyl-N'-benzoyl-N'-tert-butylhydrazine [MESH:C437546] | (0|0) |
(0|0|0) |
| - 1: | N-acetyl-N-(2-methoxycarbonylbenzyl)-2-phenoxyaniline [MESH:C526797] | (0|0) |
(0|0|0) |
| - 1: | N-benzoyl-N'-phenyl-2,6-diaminobenzoic acid [MESH:C006003] | (0|0) |
(0|0|0) |
| - 1: | N-hydroxysuccinimide 4-benzoylbenzoate [MESH:C110273] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl 3-((131)I)iodo-4-phosphonomethylbenzoate [MESH:C478639] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl 3-(trimethylstannyl)benzoate [MESH:C061345] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl 3-astatobenzoate [MESH:C504226] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl 4-(fluoromethyl)benzoate [MESH:C092711] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl 4-(tri-n-butylstannyl)benzoate [MESH:C061344] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl 4-bromobenzoate [MESH:C422194] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl 4-guanidinomethyl-3-iodobenzoate [MESH:C438937] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate [MESH:C081497] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl benzoate [MESH:C488878] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl-2,4-dimethoxy-3-(tributylstannyl)benzoate [MESH:C069574] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl-2,4-dimethoxy-3-(trimethylstannyl)benzoate [MESH:C069573] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl-3-(tri-n-butylstannyl)benzoate [MESH:C055156] | (0|0) |
(0|0|0) |
| - 1: | N-succinimidyl-4-fluorobenzoate [MESH:C075713] | (0|0) |
(0|0|0) |
| - 1: | NC 67722 [MESH:C112667] | (0|0) |
(0|0|0) |
| - 1: | NPC 18915 [MESH:C112691] | (0|0) |
(0|0|0) |
| - 1: | NS 1652 [MESH:C405615] | (0|0) |
(0|0|0) |
| - 1: | NSC 629243 [MESH:C083308] | (0|0) |
(0|0|0) |
| - 1: | NSC13345 [MESH:C000601669] | (0|0) |
(0|0|0) |
| - 1: | NSC681152 [MESH:C587492] | (0|0) |
(0|0|0) |
| - 1: | ONO-8539 [MESH:C000629829] | (0|0) |
(0|0|0) |
| - 1: | ONO-AE3-240 [MESH:C567964] | (0|0) |
(0|0|0) |
| - 1: | ONO-FO 349-01 [MESH:C116985] | (0|0) |
(0|0|0) |
| - 1: | Osmaron B [MESH:C079524] | (0|0) |
(0|0|0) |
| - 1: | PAT-048 [MESH:C000621188] | (0|0) |
(0|0|0) |
| - 1: | PLA-695 [MESH:C586663] | (0|0) |
(0|0|0) |
| - 1: | PRL-8-53 [MESH:C006732] | (0|0) |
(0|0|0) |
| - 1: | Plax [MESH:C070868] | (0|0) |
(0|0|0) |
| - 1: | RP 66471 [MESH:C091972] | (0|0) |
(0|0|0) |
| - 1: | RU 79181 [MESH:C466036] | (0|0) |
(0|0|0) |
| - 1: | Re 80 [MESH:C085268] | (0|0) |
(0|0|0) |
| - 1: | Ro 41-5253 [MESH:C084904] | (4|2) |
(4|1|0) |
| - 1: | S-benzoic-O,O-dimethyl phosphorodithioic anhydride [MESH:C011684] | (0|0) |
(0|0|0) |
| - 1: | S-benzoyl-3-mercapto-2-methylpropanoyl chloride [MESH:C054828] | (0|0) |
(0|0|0) |
| - 1: | SDZ 281 977 [MESH:C098084] | (0|0) |
(0|0|0) |
| - 1: | SDZ 53-450 [MESH:C094090] | (0|0) |
(0|0|0) |
| - 1: | SDZ FOX 988 [MESH:C094089] | (0|0) |
(0|0|0) |
| - 1: | SPL-334 [MESH:C000602674] | (0|0) |
(0|0|0) |
| - 1: | SR 11234 [MESH:C097595] | (0|0) |
(0|0|0) |
| - 1: | SR 11237 [MESH:C087130] | (2|2) |
(2|1|0) |
| - 1: | Sal Curb [MESH:C083989] | (0|0) |
(0|0|0) |
| - 1: | Shade UVAGuard [MESH:C081266] | (0|0) |
(0|0|0) |
| - 1: | Sig 8304 [MESH:C050056] | (0|0) |
(0|0|0) |
| - 1: | T 3095 [MESH:C533994] | (0|0) |
(0|0|0) |
| - 1: | T 3157 [MESH:C533995] | (0|0) |
(0|0|0) |
| - 1: | TAC 101 [MESH:C112689] | (0|0) |
(0|0|0) |
| - 1: | TAK-615 [MESH:C000628735] | (0|0) |
(0|0|0) |
| - 1: | TEI 8364 [MESH:C097356] | (0|0) |
(0|0|0) |
| - 1: | VGA1155 [MESH:C487956] | (0|0) |
(0|0|0) |
| - 1: | WB1106 [MESH:C526173] | (0|0) |
(0|0|0) |
| - 1: | Whitfield's Ointment [MESH:C023697] | (0|0) |
(0|0|0) |
| - 1: | ZCR 2060 [MESH:C091433] | (0|0) |
(0|0|0) |
| - 1: | ZK 4044 [MESH:C502734] | (0|0) |
(0|0|0) |
| - 1: | ZL006 cyclohexyl ester [MESH:C000621247] | (0|0) |
(0|0|0) |
| - 1: | acebilustat [MESH:C000625351] | (0|0) |
(0|0|0) |
| - 1: | aduncumene [MESH:C494627] | (0|0) |
(0|0|0) |
| - 1: | alofanib [MESH:C000610985] | (0|0) |
(0|0|0) |
| - 1: | alpha-methyl-4-carboxyphenylglycine [MESH:C079694] | (0|0) |
(0|0|0) |
| - 1: | amathamide D [MESH:C572713] | (0|0) |
(0|0|0) |
| - 1: | amidepsine E [MESH:C102429] | (0|0) |
(0|0|0) |
| - 1: | amino propynyl benzoic acid [MESH:C478318] | (0|0) |
(0|0|0) |
| - 1: | amino-beta-benzoylpropionic acid [MESH:C400970] | (0|0) |
(0|0|0) |
| - 1: | amylocaine [MESH:C015677] | (0|0) |
(0|0|0) |
| - 1: | antrolone [MESH:C000629424] | (0|0) |
(0|0|0) |
| - 1: | aplaviroc [MESH:C499671] | (0|0) |
(0|0|0) |
| - 1: | arieianal [MESH:C505307] | (0|0) |
(0|0|0) |
| - 1: | asarumin A [MESH:C069458] | (0|0) |
(0|0|0) |
| - 1: | asarumin B [MESH:C069459] | (0|0) |
(0|0|0) |
| - 1: | asiatoate A [MESH:C583109] | (0|0) |
(0|0|0) |
| - 1: | asiatoate B [MESH:C583110] | (0|0) |
(0|0|0) |
| - 1: | aspyran [MESH:C578645] | (0|0) |
(0|0|0) |
| - 1: | avobenzone, ensulizole, enzacamene drug combination [MESH:C083318] | (0|0) |
(0|0|0) |
| - 1: | baeomycesic acid [MESH:C496299] | (0|0) |
(0|0|0) |
| - 1: | bencain [MESH:C006689] | (0|0) |
(0|0|0) |
| - 1: | benexate [MESH:C057164] | (0|0) |
(0|0|0) |
| - 1: | benzene-1,2,4,5-tetracarboxylate [MESH:C542967] | (0|0) |
(0|0|0) |
| - 1: | benzoic acid 2-(2,4,6-trichlorophenyl)hydrazide [MESH:C011403] | (0|0) |
(0|0|0) |
| - 1: | benzoic acid, malic acid, propylene glycol, salicylic acid drug combination [MESH:C045341] | (0|0) |
(0|0|0) |
| - 1: | benzoic anhydride [MESH:C102988] | (0|0) |
(0|0|0) |
| - 1: | benzomate [MESH:C037524] | (0|0) |
(0|0|0) |
| - 1: | benzoyl N-(benzyloxycarbonyl)aminomethyl phosphonate [MESH:C506014] | (0|0) |
(0|0|0) |
| - 1: | benzoyl bromide [MESH:C009852] | (0|0) |
(0|0|0) |
| - 1: | benzoyl chloride [MESH:C013409] | (0|0) |
(0|0|0) |
| - 1: | benzoyl glucuronide [MESH:C037620] | (0|0) |
(0|0|0) |
| - 1: | benzoyl phosphate [MESH:C012217] | (0|0) |
(0|0|0) |
| - 1: | benzoyl-1,4-dipyrrolidinone [MESH:C074605] | (0|0) |
(0|0|0) |
| - 1: | benzoyl-adenylate [MESH:C116594] | (0|0) |
(0|0|0) |
| - 1: | benzoylacrylic acid [MESH:C400967] | (0|0) |
(0|0|0) |
| - 1: | benzoylborane [MESH:C523472] | (0|0) |
(0|0|0) |
| - 1: | benzoylpropionic acid [MESH:C400972] | (0|0) |
(0|0|0) |
| - 1: | benzyl benzoate [MESH:C006723] | (0|0) |
(0|0|0) |
| - 1: | biphenyl-2-carboxylic acid [MESH:C113592] | (0|0) |
(0|0|0) |
| - 1: | biphenyl-3-carboxylic acid [MESH:C102064] | (0|0) |
(0|0|0) |
| - 1: | biphenylcarboxylic acid butanediol ester [MESH:C529241] | (0|0) |
(0|0|0) |
| - 1: | bis(2-aminopyridine-N)bis(benzoato-O)zinc(II) [MESH:C413339] | (0|0) |
(0|0|0) |
| - 1: | bis(2-carboxyphenyl)telluride [MESH:C111214] | (0|0) |
(0|0|0) |
| - 1: | bis(4-carboxybenzyl)hyponitrite [MESH:C551173] | (0|0) |
(0|0|0) |
| - 1: | bis(benzoyloxyethyl)terephthalate [MESH:C546855] | (0|0) |
(0|0|0) |
| - 1: | bis(imidazolium) 2,2'-dithiodibenzoate [MESH:C544579] | (0|0) |
(0|0|0) |
| - 1: | bispyribac [MESH:C549011] | (0|0) |
(0|0|0) |
| - 1: | butyl 4-(butyryloxy)benzoate [MESH:C531508] | (0|0) |
(0|0|0) |
| - 1: | butyl 4-benzoyloxymethylbenzoate [MESH:C525324] | (0|0) |
(0|0|0) |
| - 1: | butylammonium 2,5-dihydroxybenzoate [MESH:C518936] | (0|0) |
(0|0|0) |
| - 1: | caffeine, sodium benzoate drug combination [MESH:C025741] | (0|0) |
(0|0|0) |
| - 1: | calvatic acid [MESH:C010057] | (0|0) |
(0|0|0) |
| - 1: | cannabigerolic acid [MESH:C100679] | (0|0) |
(0|0|0) |
| - 1: | capsazocaine [MESH:C108689] | (0|0) |
(0|0|0) |
| - 1: | carzenide [MESH:C001910] | (0|0) |
(0|0|0) |
| - 1: | cellulose acetate trimellitate [MESH:C070228] | (0|0) |
(0|0|0) |
| - 1: | chloroisosulochrin [MESH:C562278] | (0|0) |
(0|0|0) |
| - 1: | cholesteryl 4-fluorobenzoate [MESH:C120325] | (0|0) |
(0|0|0) |
| - 1: | chromazurol B [MESH:C020264] | (0|0) |
(0|0|0) |
| - 1: | chrysamine G [MESH:C092559] | (0|0) |
(0|0|0) |
| - 1: | cinnamyl benzoate [MESH:C526330] | (0|0) |
(0|0|0) |
| - 1: | cis-4-((3H,3aH,6aH)-3-(4-methoxyphenyl)-4,6-dioxo-2p-tolydihydro-2H-pyrrolo(3,4-d)isoxazol-5(3H,6H,6 [MESH:C571817] | (0|0) |
(0|0|0) |
| - 1: | clavatoic acid [MESH:C457255] | (0|0) |
(0|0|0) |
| - 1: | cloransulam-methyl [MESH:C412472] | (0|0) |
(0|0|0) |
| - 1: | compound 3289-5066 [MESH:C542872] | (0|0) |
(0|0|0) |
| - 1: | compound 3289-8625 [MESH:C542873] | (0|0) |
(0|0|0) |
| - 1: | compound 44Bu [MESH:C527036] | (0|0) |
(0|0|0) |
| - 1: | confluentic acid [MESH:C089056] | (0|0) |
(0|0|0) |
| - 1: | crassinervic acid [MESH:C494626] | (0|0) |
(0|0|0) |
| - 1: | cumic acid [MESH:C055607] | (0|0) |
(0|0|0) |
| - 1: | cumyl dithiobenzoate [MESH:C511372] | (0|0) |
(0|0|0) |
| - 1: | curculigoside [MESH:C477170] | (0|0) |
(0|0|0) |
| - 1: | curcuminol F [MESH:C544625] | (0|0) |
(0|0|0) |
| - 1: | cytonic acid A [MESH:C410913] | (0|0) |
(0|0|0) |
| - 1: | cytonic acid B [MESH:C410914] | (0|0) |
(0|0|0) |
| - 1: | deoxy-tomentellin [MESH:C412947] | (0|0) |
(0|0|0) |
| - 1: | dextran benzenehexacarboxylate [MESH:C087947] | (0|0) |
(0|0|0) |
| - 1: | diaquatetrakis(mu-2,6-difluorobenzoato-kappaO-kappaO')dicopper(II) [MESH:C085310] | (0|0) |
(0|0|0) |
| - 1: | diasarone-I [MESH:C000628041] | (0|0) |
(0|0|0) |
| - 1: | diazepinylbenzoic acid [MESH:C438269] | (0|0) |
(0|0|0) |
| - 1: | diethylene glycol dibenzoate [MESH:C542008] | (0|0) |
(0|0|0) |
| - 1: | dimethyl 6,6'-dimethoxy-3,3',5,5'-tetramethylbiphenyl-2,2'-dicarboxylate [MESH:C401315] | (0|0) |
(0|0|0) |
| - 1: | dimethylaminoethyl p-butylaminobenzoate [MESH:C111552] | (0|0) |
(0|0|0) |
| - 1: | dimethylaminoethylbenzoate [MESH:C002222] | (0|0) |
(0|0|0) |
| - 1: | dioschrin [MESH:C000593738] | (0|0) |
(0|0|0) |
| - 1: | diphenylcarboxylate [MESH:C062963] | (0|0) |
(0|0|0) |
| - 1: | ecopladib [MESH:C519110] | (0|0) |
(0|0|0) |
| - 1: | efipladib [MESH:C531068] | (0|0) |
(0|0|0) |
| - 1: | eltrombopag [MESH:C520809] | (0|0) |
(0|0|0) |
| - 1: | epiphorellic acid-1 [MESH:C518877] | (0|0) |
(0|0|0) |
| - 1: | estradiol-17-benzoate [MESH:C514340] | (0|0) |
(0|0|0) |
| - 1: | ethanolamine benzoate [MESH:C041768] | (0|0) |
(0|0|0) |
| - 1: | ethyl 2-(N-((4-iodo-6-methoxypyrimidin-2-yl)carbamoyl)sulfamoyl)benzoate [MESH:C579727] | (0|0) |
(0|0|0) |
| - 1: | ethyl 2-(aminosulfonyl)benzoate [MESH:C471072] | (0|0) |
(0|0|0) |
| - 1: | ethyl 3,5-bis(acetylamino)-2,4,6-triidobenzoate [MESH:C111724] | (0|0) |
(0|0|0) |
| - 1: | ethyl 3,5-dihydroxy-2-propionylbenzoate [MESH:C000618932] | (0|0) |
(0|0|0) |
| - 1: | ethyl 3,5-dimethoxy-2-propionylbenzoate [MESH:C000618931] | (0|0) |
(0|0|0) |
| - 1: | ethyl 4-((3-amino-2-naphthyl)aminomethyl)benzoate [MESH:C110817] | (0|0) |
(0|0|0) |
| - 1: | ethyl 4-(2-(6-methyl-3-pyridyloxy)butyloxy)benzoate [MESH:C486872] | (0|0) |
(0|0|0) |
| - 1: | ethyl 4-(2-benzylhexyloxy)benzoate [MESH:C567985] | (0|0) |
(0|0|0) |
| - 1: | ethyl 4-(4-((2-hydroxy-3-(4-hydroxy-3-((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoat [MESH:C521336] | (0|0) |
(0|0|0) |
| - 1: | ethyl 4-(benzyloxy)-3-((3-(4-methoxytetrahydro-2H-pyran-4-yl)phenyl)methylsulfonamido)benzoate [MESH:C559083] | (0|0) |
(0|0|0) |
| - 1: | ethyl 4-benzyloxybenzoate [MESH:C015618] | (0|0) |
(0|0|0) |
| - 1: | ethyl 4-ethoxybenzoate [MESH:C099039] | (0|0) |
(0|0|0) |
| - 1: | ethyl 5-(4-aminophenyl)-3-amino-2,4-dicyanobenzoate [MESH:C585231] | (0|0) |
(0|0|0) |
| - 1: | ethyl-2-acetoxyethylbenzoate [MESH:C444540] | (0|0) |
(0|0|0) |
| - 1: | ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid [MESH:C034814] | (2|1) |
(2|2|0) |
| - 1: | ethylmercury thiosalicylate [MESH:C418469] | (0|0) |
(0|0|0) |
| - 1: | etripamil [MESH:C000656646] | (0|0) |
(0|0|0) |
| - 1: | exophillic acid [MESH:C484148] | (0|0) |
(0|0|0) |
| - 1: | fenpyroximate [MESH:C415144] | (2|2) |
(2|1|0) |
| - 1: | ferrocene dicarboxylic acid [MESH:C517217] | (0|0) |
(0|0|0) |
| - 1: | ganglerone [MESH:C007824] | (0|0) |
(0|0|0) |
| - 1: | gaudichaudianic acid [MESH:C494629] | (0|0) |
(0|0|0) |
| - 1: | gaultherin A [MESH:C477164] | (0|0) |
(0|0|0) |
| - 1: | glucosyringic acid [MESH:C092651] | (0|0) |
(0|0|0) |
| - 1: | gyrophoric acid [MESH:C120727] | (1|1) |
(1|0|0) |
| - 1: | halazone [MESH:C053526] | (0|0) |
(0|0|0) |
| - 1: | hexyl-4-trifluoroacetylbenzoate [MESH:C552961] | (0|0) |
(0|0|0) |
| - 1: | hostmaniane [MESH:C494628] | (0|0) |
(0|0|0) |
| - 1: | houttuynoside A [MESH:C546135] | (0|0) |
(0|0|0) |
| - 1: | imidazolidin-2-one-4-carboxylate [MESH:C530351] | (0|0) |
(0|0|0) |
| - 1: | isobutyl benzoate [MESH:C087766] | (0|0) |
(0|0|0) |
| - 1: | isosulochrin [MESH:C562277] | (0|0) |
(0|0|0) |
| - 1: | leukadherin-1 [MESH:C000589733] | (0|0) |
(0|0|0) |
| - 1: | m-imazamethabenz-methyl [MESH:C521119] | (0|0) |
(0|0|0) |
| - 1: | m-terphenyl 4-mercaptomethyl-2,6-diphenylbenzoic acid [MESH:C506104] | (0|0) |
(0|0|0) |
| - 1: | mellitic acid [MESH:C015339] | (0|0) |
(0|0|0) |
| - 1: | mepramidil [MESH:C001089] | (0|0) |
(0|0|0) |
| - 1: | mesitoyl chloride [MESH:C016557] | (0|0) |
(0|0|0) |
| - 1: | mesitylenecarboxylic acid [MESH:C019471] | (0|0) |
(0|0|0) |
| - 1: | methyl 2,4-dihydroxy-3,6-dimethyl benzoate [MESH:C472636] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-(((((4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)benzoate [MESH:C413983] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-(((2Z)-2-(2,5-dichlorothiophen-3-yl)-2-(hydroxyimino)ethyl)sulfanyl)benzoate [MESH:C577886] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-(2-(hydroxy(2-nitrophenyl)methyl)acryloyloxy)benzoate [MESH:C579295] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-(methylthio)benzoate [MESH:C571009] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-(octylsulfinyl)benzoate [MESH:C108701] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-O-acetyl-3-O-toluoyltalopyranoside [MESH:C572058] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-benzoylbenzoate [MESH:C000616131] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-hydroxy-4-methoxy-6-methylbenzoate [MESH:C474620] | (0|0) |
(0|0|0) |
| - 1: | methyl 2-isothiocyanatobenzoate [MESH:C570556] | (0|0) |
(0|0|0) |
| - 1: | methyl 3'-chloro-4'-(mannopyranosyloxy)biphenyl-4-carboxylate [MESH:C555221] | (0|0) |
(0|0|0) |
| - 1: | methyl 3,4,5-triacetoxybenzoate [MESH:C408678] | (0|0) |
(0|0|0) |
| - 1: | methyl 3-(1-acetoxy-3-methylbutyl)-2-methoxy-6-(2- methoxy-4-methyl-6-(2-oxopropyl)phenoxy)benzoate [MESH:C540396] | (0|0) |
(0|0|0) |
| - 1: | methyl 3-chloro-3'-fluoro-4'-(1-(((1-((trifluoroacetyl)amino)cyclopropyl)carbonyl)amino)ethyl)-1,1'- [MESH:C517804] | (0|0) |
(0|0|0) |
| - 1: | methyl 3-chloro-6-methoxy-2-methylbenzoate [MESH:C000610092] | (0|0) |
(0|0|0) |
| - 1: | methyl 3-toluate [MESH:C034325] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-((1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethoxy)methyl)benzoate [MESH:C000605576] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)aminocarbonyl)-2-(qui [MESH:C552746] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-((E)-(5-(3,4-dimethoxyphenyl)-2-oxofuran-3(2H)-ylidene)methyl)benzoate [MESH:C582865] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-(2'-hydroxy-3'-butynoxy)benzoate [MESH:C492602] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-(3-ethyl-3-hydroxymethyltriazen-1-yl)benzoate [MESH:C072258] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-(methylthio)benzoate [MESH:C051442] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-anisate [MESH:C539391] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-azido-2,3,5,6-tetrafluorobenzoate [MESH:C098120] | (0|0) |
(0|0|0) |
| - 1: | methyl 4-methoxy-3-(3'-hydroxy-2'-methyl)propionyloxybenzoate [MESH:C558103] | (0|0) |
(0|0|0) |
| - 1: | methyl 6-eicosanyl-2-hydroxy-4-methoxybenzoate [MESH:C503470] | (0|0) |
(0|0|0) |
| - 1: | methyl benzoate [MESH:C044605] | (0|0) |
(0|0|0) |
| - 1: | methyl-2-(2-(N,N-diethylamino)acetamido)-3-cyano-4,5-dimethylbenzoate [MESH:C433213] | (0|0) |
(0|0|0) |
| - 1: | methyl-2-(2-(piperidino)acetamido)-3-cyano-4,5-dimethylbenzoate [MESH:C433214] | (0|0) |
(0|0|0) |
| - 1: | methyl-2-(propanamide-2'-methoxycarbonyl)benzoate [MESH:C110234] | (0|0) |
(0|0|0) |
| - 1: | methyl-3-(2-propenyl)-4-(2-propenyloxy)benzoate [MESH:C457203] | (0|0) |
(0|0|0) |
| - 1: | methyl-4-((2-phenylhydrazono)methyl)benzoate [MESH:C000604639] | (0|0) |
(0|0|0) |
| - 1: | methyl-4-methoxy-3-(3-methyl-2-butenoyl) benzoate [MESH:C423823] | (0|0) |
(0|0|0) |
| - 1: | methyl-5-sulphamoyl-2-methoxybenzoate [MESH:C121111] | (0|0) |
(0|0|0) |
| - 1: | methylamino-2-phenyl-2-butyl-3,4,5-trimethoxybenzoate [MESH:C412875] | (0|0) |
(0|0|0) |
| - 1: | methylseleno-2-benzoic acid [MESH:C019488] | (0|0) |
(0|0|0) |
| - 1: | mitorubrin [MESH:C521221] | (0|0) |
(0|0|0) |
| - 1: | mitorubrinic acid [MESH:C433878] | (0|0) |
(0|0|0) |
| - 1: | naokangning [MESH:C572199] | (0|0) |
(0|0|0) |
| - 1: | netarsudil [MESH:C000603944] | (0|0) |
(0|0|0) |
| - 1: | nigerloxin [MESH:C469528] | (0|0) |
(0|0|0) |
| - 1: | o-diphenylphosphanylbenzoyl [MESH:C544846] | (0|0) |
(0|0|0) |
| - 1: | o-hydroxydithiobenzoate [MESH:C475810] | (0|0) |
(0|0|0) |
| - 1: | obtusatic acid [MESH:C411222] | (0|0) |
(0|0|0) |
| - 1: | octyl triazone [MESH:C466618] | (0|0) |
(0|0|0) |
| - 1: | oleyl benzoate [MESH:C403615] | (0|0) |
(0|0|0) |
| - 1: | onosmin A [MESH:C504486] | (0|0) |
(0|0|0) |
| - 1: | onosmin B [MESH:C504487] | (0|0) |
(0|0|0) |
| - 1: | opianic acid [MESH:C005281] | (0|0) |
(0|0|0) |
| - 1: | ortho-(1-naphthoyl)benzoic acid [MESH:C115036] | (0|0) |
(0|0|0) |
| - 1: | p-(2,3-di(2-bromoethylthio)-n-propyloxy)benzoic acid [MESH:C000919] | (0|0) |
(0|0|0) |
| - 1: | p-(2-(N-butylcarbazol-3'-yl)ethen-1-yl)benzoic acid [MESH:C568135] | (0|0) |
(0|0|0) |
| - 1: | p-(4-ferrocenylbuta-1,3-dien-1-yl)benzoic acid [MESH:C568133] | (0|0) |
(0|0|0) |
| - 1: | p-(N-propynoylamino)toluic acid [MESH:C581278] | (0|0) |
(0|0|0) |
| - 1: | p-acryloyloxybenzoic acid [MESH:C000595761] | (0|0) |
(0|0|0) |
| - 1: | p-imazamethabenz-methyl [MESH:C521118] | (0|0) |
(0|0|0) |
| - 1: | paeoniflorin-4-ethyl ether [MESH:C510981] | (0|0) |
(0|0|0) |
| - 1: | pentafluorobenzoic acid [MESH:C090819] | (0|0) |
(0|0|0) |
| - 1: | pentafluorobenzoic anhydride [MESH:C060431] | (0|0) |
(0|0|0) |
| - 1: | pentafluorobenzoyl chloride [MESH:C014737] | (0|0) |
(0|0|0) |
| - 1: | pentafluorobenzoyl-N-phenylethylamine [MESH:C059212] | (0|0) |
(0|0|0) |
| - 1: | perlatolic acid [MESH:C522034] | (0|0) |
(0|0|0) |
| - 1: | peroxybenzoic acid [MESH:C017611] | (0|0) |
(0|0|0) |
| - 1: | phosphofarnesylthiosalicylic acid [MESH:C000591155] | (0|0) |
(0|0|0) |
| - 1: | piperonylic acid [MESH:C005455] | (0|0) |
(0|0|0) |
| - 1: | piroxicam benzoate [MESH:C477988] | (0|0) |
(0|0|0) |
| - 1: | poliothrysoside [MESH:C477961] | (0|0) |
(0|0|0) |
| - 1: | polluxochrin [MESH:C000593736] | (0|0) |
(0|0|0) |
| - 1: | poloxin [MESH:C569433] | (0|0) |
(0|0|0) |
| - 1: | poly(3,5-dihydroxy benzoic acid) [MESH:C532416] | (0|0) |
(0|0|0) |
| - 1: | poly(p-(carboxyethylformamido) benzoic anhydride) [MESH:C469869] | (0|0) |
(0|0|0) |
| - 1: | populin [MESH:C058045] | (0|0) |
(0|0|0) |
| - 1: | prasinic acid [MESH:C578922] | (0|0) |
(0|0|0) |
| - 1: | propanocaine [MESH:C573539] | (0|0) |
(0|0|0) |
| - 1: | propoxycarbazone [MESH:C471815] | (0|0) |
(0|0|0) |
| - 1: | propyl 4-(2-(4,6-dimethoxypyrimidin-2-yloxy)benzylamino)benzoate [MESH:C543844] | (0|0) |
(0|0|0) |
| - 1: | propynyl benzoate [MESH:C059565] | (0|0) |
(0|0|0) |
| - 1: | pyrimethaminium 2,4-dichlorobenzoate [MESH:C548559] | (0|0) |
(0|0|0) |
| - 1: | pyrimethaminium 4-methylbenzoate [MESH:C548562] | (0|0) |
(0|0|0) |
| - 1: | pyrithiobac sodium [MESH:C401888] | (0|0) |
(0|0|0) |
| - 1: | pyromellitic acid [MESH:C012018] | (0|0) |
(0|0|0) |
| - 1: | pyromellitic acid dianhydride-2-hydroxyethyl methacrylate adduct [MESH:C043042] | (0|0) |
(0|0|0) |
| - 1: | pyromellitic dianhydride [MESH:C012019] | (0|0) |
(0|0|0) |
| - 1: | pyromellitic dianhydride glycerol dimethacrylate adduct [MESH:C080129] | (0|0) |
(0|0|0) |
| - 1: | radamide [MESH:C540759] | (0|0) |
(0|0|0) |
| - 1: | rrcc-2,8,14,20-tetra-(n-decyl-(n-decylsulfido))-4,6,10,12,16,18,22,24-octa-O-(4-iod0benzoyl)resorc(4 [MESH:C497485] | (0|0) |
(0|0|0) |
| - 1: | rubiginosin A [MESH:C488884] | (0|0) |
(0|0|0) |
| - 1: | rubiginosin B [MESH:C488886] | (0|0) |
(0|0|0) |
| - 1: | sanleng diphenylacetypene [MESH:C542620] | (0|0) |
(0|0|0) |
| - 1: | sodium N-(4-dodecyloxybenzoyl)-L-valinate [MESH:C512558] | (0|0) |
(0|0|0) |
| - 1: | sodium N-(4-n-dodecyloxybenzoyl)-L-isoleucinate [MESH:C515106] | (0|0) |
(0|0|0) |
| - 1: | sodium N-(4-n-dodecyloxybenzoyl)-L-leucinate [MESH:C515105] | (0|0) |
(0|0|0) |
| - 1: | solabegron [MESH:C523977] | (0|0) |
(0|0|0) |
| - 1: | sphaerophorin [MESH:C518876] | (0|0) |
(0|0|0) |
| - 1: | spinosulfate A [MESH:C498228] | (0|0) |
(0|0|0) |
| - 1: | sucrose octabenzoic acid [MESH:C067056] | (0|0) |
(0|0|0) |
| - 1: | sulochrin [MESH:C111298] | (0|0) |
(0|0|0) |
| - 1: | susalimod [MESH:C119880] | (0|0) |
(0|0|0) |
| - 1: | syreiteate A [MESH:C586000] | (0|0) |
(0|0|0) |
| - 1: | syreiteate B [MESH:C586001] | (0|0) |
(0|0|0) |
| - 1: | tamibarotene [MESH:C061133] | (4|6) |
(7|5|2) |
| - 1: | tecarfarin [MESH:C547288] | (0|0) |
(0|0|0) |
| - 1: | teferdin [MESH:C507391] | (0|0) |
(0|0|0) |
| - 1: | terbufibrol [MESH:C020508] | (0|0) |
(0|0|0) |
| - 1: | tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoate [MESH:C000607828] | (0|0) |
(0|0|0) |
| - 1: | tert-butyl peroxybenzoate [MESH:C060534] | (0|0) |
(0|0|0) |
| - 1: | thielavin G [MESH:C471244] | (0|0) |
(0|0|0) |
| - 1: | thielocin B1 [MESH:C000632166] | (0|0) |
(0|0|0) |
| - 1: | thiobenzoate chromophore [MESH:C489064] | (0|0) |
(0|0|0) |
| - 1: | thomasidioic acid [MESH:C475898] | (0|0) |
(0|0|0) |
| - 1: | tiankuizi [MESH:C578812] | (0|0) |
(0|0|0) |
| - 1: | tioctilate [MESH:C019577] | (0|0) |
(0|0|0) |
| - 1: | tolycaine [MESH:C105695] | (0|0) |
(0|0|0) |
| - 1: | trans-(tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-5-oxofuran-3-yl)methyl benzoate [MESH:C511976] | (0|0) |
(0|0|0) |
| - 1: | tri-(2-ethylhexyl)trimellitate [MESH:C036101] | (0|0) |
(0|0|0) |
| - 1: | triethyl 4,4',4'-(benzene-1,3,5-triyltris(ethyne-2,1-diyl))tribenzoate [MESH:C000596209] | (0|0) |
(0|0|0) |
| - 1: | triflusulfuron-methyl [MESH:C413391] | (0|0) |
(0|0|0) |
| - 1: | trioctyl trimellitate [MESH:C034367] | (0|0) |
(0|0|0) |
| - 1: | tris(4-methylbenzoate)cellulose [MESH:C090722] | (0|0) |
(0|0|0) |
| - 1: | trollioside [MESH:C484703] | (0|0) |
(0|0|0) |
| - 1: | tucaresol [MESH:C059629] | (0|0) |
(0|0|0) |
| - 1: | urorost [MESH:C060246] | (0|0) |
(0|0|0) |
| - 1: | uvacanol F [MESH:C551930] | (0|0) |
(0|0|0) |
| - 1: | uvacanol G [MESH:C551931] | (0|0) |
(0|0|0) |
| - 1: | uvacanol H [MESH:C551932] | (0|0) |
(0|0|0) |
| - 1: | wenyujinoside [MESH:C544627] | (0|0) |
(0|0|0) |
Jump to [ Top · Hierarchy ]
Superfamily( show details)
Highlighted in gray are those with FDR_all>0.001
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Cu,Zn superoxide dismutase-like | 0 | DIRECT |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| beta-lactamase/transpeptidase-like | 0 | DIRECT |
| Nitric oxide (NO) synthase oxygenase domain | 0 | DIRECT |
| MOSC N-terminal domain-like | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| AhpD-like | 0 | DIRECT |
| SMAD MH1 domain | 0 | DIRECT |
| Nicotinate/Quinolinate PRTase C-terminal domain-like | 0 | DIRECT |
| alpha-ketoacid dehydrogenase kinase, N-terminal domain | 0 | DIRECT |
| TB module/8-cys domain | 0 | DIRECT |
| FAD-linked oxidases, C-terminal domain | 0 | DIRECT |
| BSD domain-like | 0 | DIRECT |
| Integrin beta tail domain | 0 | DIRECT |
| N-terminal domain of cbl (N-cbl) | 0 | DIRECT |
| Fibrinogen coiled-coil and central regions | 0 | DIRECT |
| Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| Aminoacid dehydrogenase-like, N-terminal domain | 0 | DIRECT |
| Vasodilator-stimulated phosphoprotein, VASP, tetramerisation domain | 0 | DIRECT |
| RILP dimerisation region | 0 | DIRECT |
| Leucine zipper domain | 0.00001832 | DIRECT |
| A DNA-binding domain in eukaryotic transcription factors | 0.00004131 | DIRECT |
| PYP-like sensor domain (PAS domain) | 0.0002327 | DIRECT |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.000315 | DIRECT |
| EGF/Laminin | 0.0003413 | DIRECT |
| Kringle-like | 0.002171 | INHERITED FROM: Aspirin || Hydroxybenzoates |
| Growth factor receptor domain | 0.002446 | INHERITED FROM: Benzamides || Chloromercuribenzoates |
| Nuclear receptor ligand-binding domain | 0.002708 | INHERITED FROM: Bezafibrate || 4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid || Parabens || DEET || ethyl-p-hydroxybenzoate || fenpyroximate || 3-phenoxybenzoic acid || Chlorobenzoates || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || SR 11237 || Fenamates || isobutyl-4-hydroxybenzoate || Aminobenzoates || Hydroxybenzoates || benzylparaben || homosalate || isobutylparaben || Ro 41-5253 |
| SH2 domain | 0.003528 | INHERITED FROM: Imatinib Mesylate || tamibarotene |
| HLH, helix-loop-helix DNA-binding domain | 0.01227 | INHERITED FROM: 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid || Benzocaine || butamben |
| Metallothionein | 0.0139 | INHERITED FROM: Chlorobenzoates || Mercuribenzoates || Chloromercuribenzoates |
| Fibronectin type III | 0.01896 | INHERITED FROM: Benzamides || 2-(oxalylamino)benzoic acid |
| Cytochrome P450 | 0.01919 | INHERITED FROM: Bezafibrate || DEET || 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || GW 3965 || 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide || hexafluoron || Fenamates || 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid || Aminobenzoates || dimethocaine || triflumuron |
| Protein kinase-like (PK-like) | 0.03379 | INHERITED FROM: Triiodobenzoic Acids || Imatinib Mesylate || AG-012986 || N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide || tamibarotene || Hydroxybenzoates |
| MFS general substrate transporter | 0.03871 | INHERITED FROM: Aminohippuric Acids || p-Aminohippuric Acid || Salicylic Acid || Fenamates || Bumetanide || 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid || Aminobenzoates || Sulpiride || Hippurates |
| HD-domain/PDEase-like | 0.03993 | INHERITED FROM: Benzamides || Roflumilast |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.04704 | INHERITED FROM: Chloromercuribenzoates |
| Integrin domains | 0.04811 | INHERITED FROM: Salicylates |
| TNF receptor-like | 0.04971 | INHERITED FROM: Parabens || Hydroxybenzoates |
| Thyroglobulin type-1 domain | 0.05725 | INHERITED FROM: Chloromercuribenzoates |
| DEATH domain | 0.06018 | INHERITED FROM: Parabens || Imatinib Mesylate || dehydroxymethylepoxyquinomicin || Anacardic Acids || Hydroxybenzoates || propylparaben |
| STAT | 0.102 | INHERITED FROM: Aspirin |
| Transcription factor STAT-4 N-domain | 0.102 | INHERITED FROM: Aspirin |
| Caspase-like | 0.1362 | INHERITED FROM: Remoxipride || Parabens || Imatinib Mesylate || dehydroxymethylepoxyquinomicin || NCQ 344 || Fenamates || NCX 4040 || Aminobenzoates || 3-bromoacetylamino benzoic acid ethyl ester || Anacardic Acids || Hydroxybenzoates || propylparaben || Bromobenzoates |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.15 | INHERITED FROM: Chloromercuribenzoates |
| Immunoglobulin | 0.1553 | INHERITED FROM: HX 630 |
| Bcl-2 inhibitors of programmed cell death | 0.1772 | INHERITED FROM: Triiodobenzoic Acids || Parabens || Imatinib Mesylate || Hydrolyzable Tannins || Aspirin || atranorin || gyrophoric acid || Iodobenzoates || Fenamates || ortho-Aminobenzoates || BP-1-102 || Aminobenzoates || Hydroxybenzoates || propylparaben |
| Cyclin-like | 0.1865 | INHERITED FROM: Parabens || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || UF010 compound || Hydroxybenzoates || Ro 41-5253 |
| NAD(P)-linked oxidoreductase | 0.1943 | INHERITED FROM: fenamic acid || methyl salicylate || 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid || Fenamates || 4-hydroxybenzoic acid || Aminobenzoates || octyl gallate || Meclofenamic Acid || Hydroxybenzoates || Benzoic Acid || Flufenamic Acid |
| FYVE/PHD zinc finger | 0.2009 | INHERITED FROM: 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
| FAD/NAD(P)-binding domain | 0.2128 | INHERITED FROM: Nitrobenzoates |
| MHC antigen-recognition domain | 0.219 | INHERITED FROM: tamibarotene || entinostat |
| Flavoproteins | 0.2635 | INHERITED FROM: Aspirin || Fenamates || ortho-Aminobenzoates || Salicylates || Aminobenzoates || Hydroxybenzoates || Benzoic Acid |
| Inhibitor of apoptosis (IAP) repeat | 0.2664 | INHERITED FROM: dehydroxymethylepoxyquinomicin || Anacardic Acids || Hydroxybenzoates |
| E2F-DP heterodimerization region | 0.2664 | INHERITED FROM: UF010 compound |
| NAD(P)-binding Rossmann-fold domains | 0.2794 | INHERITED FROM: DEET || methyl salicylate |
| (Phosphotyrosine protein) phosphatases II | 0.2818 | INHERITED FROM: ortho-Aminobenzoates || Aminobenzoates || 2-(oxalylamino)benzoic acid |
| Arginase/deacetylase | 0.3009 | INHERITED FROM: mocetinostat |
| ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase | 0.3072 | INHERITED FROM: tamibarotene || VER-246608 |
| p53-like transcription factors | 0.3227 | INHERITED FROM: Triiodobenzoic Acids || Imatinib Mesylate || Iopamidol || Iodobenzoates || Anacardic Acids |
| 14-3-3 protein | 0.3467 | INHERITED FROM: Aspirin |
| Metalloproteases ("zincins"), catalytic domain | 0.3623 | INHERITED FROM: PD 0325901 |
| Cystine-knot cytokines | 0.4274 | INHERITED FROM: Procarbazine || MOPP protocol |
| "Winged helix" DNA-binding domain | 0.4481 | INHERITED FROM: UF010 compound |
| ABC transporter transmembrane region | 0.465 | INHERITED FROM: Bezafibrate || Imatinib Mesylate |
| Voltage-gated potassium channels | 0.562 | INHERITED FROM: Niflumic Acid || Flufenamic Acid |
| Interleukin 8-like chemokines | 0.5846 | INHERITED FROM: sirtinol || Imatinib Mesylate || Hydrolyzable Tannins || Roflumilast || Hydroxybenzoates || roflumilast N-oxide |
| SMAD/FHA domain | 0.5979 | INHERITED FROM: sirtinol |
| GST C-terminal domain-like | 0.6036 | INHERITED FROM: Fenamates || ortho-Aminobenzoates || Aminobenzoates |
| Lipocalins | 0.6451 | INHERITED FROM: Bezafibrate |
| S15/NS1 RNA-binding domain | 0.6494 | INHERITED FROM: C646 compound |
| TNF-like | 0.7812 | INHERITED FROM: Bezafibrate |
| 4-helical cytokines | 0.8996 | INHERITED FROM: Aminobenzoates || Hydroxybenzoates || FK 706 || Sodium Salicylate || Ro 41-5253 |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.9042 | INHERITED FROM: 4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide || benzamide |
| Nicotinic receptor ligand binding domain-like | 0.9042 | INHERITED FROM: 4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide || benzamide |
| UDP-Glycosyltransferase/glycogen phosphorylase | 0.9522 | INHERITED FROM: Diflunisal || Hydroxybenzoate Ethers || methyl salicylate || Salicylic Acid || Fenamates || ortho-Aminobenzoates || Aminobenzoates || Vanillic Acid |
| Thioredoxin-like | 1 | INHERITED FROM: Fenamates || ortho-Aminobenzoates |
| Prefoldin | 1 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
| Family A G protein-coupled receptor-like | 1 | INHERITED FROM: 1-(8-bromobenzo(1,2-b;4,5-b')difuran-4-yl)-2-aminopropane |
| Intermediate filament protein, coiled coil region | 1 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Cu,Zn superoxide dismutase-like | 0 | Direct |
| Nuclear receptor coactivator interlocking domain | 0 | Direct |
| beta-lactamase/transpeptidase-like | 0 | Direct |
| Nitric oxide (NO) synthase oxygenase domain | 0 | Direct |
| MOSC N-terminal domain-like | 0 | Direct |
| P-domain of calnexin/calreticulin | 0 | Direct |
| AhpD-like | 0 | Direct |
| SMAD MH1 domain | 0 | Direct |
| Nicotinate/Quinolinate PRTase C-terminal domain-like | 0 | Direct |
| alpha-ketoacid dehydrogenase kinase, N-terminal domain | 0 | Direct |
| TB module/8-cys domain | 0 | Direct |
| FAD-linked oxidases, C-terminal domain | 0 | Direct |
| BSD domain-like | 0 | Direct |
| Integrin beta tail domain | 0 | Direct |
| N-terminal domain of cbl (N-cbl) | 0 | Direct |
| Fibrinogen coiled-coil and central regions | 0 | Direct |
| Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex | 0 | Direct |
| p53 tetramerization domain | 0 | Direct |
| Aminoacid dehydrogenase-like, N-terminal domain | 0 | Direct |
| Vasodilator-stimulated phosphoprotein, VASP, tetramerisation domain | 0 | Direct |
| RILP dimerisation region | 0 | Direct |
| Leucine zipper domain | 0.00001832 | Direct |
| A DNA-binding domain in eukaryotic transcription factors | 0.00004131 | Direct |
| PYP-like sensor domain (PAS domain) | 0.0002327 | Direct |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.000315 | Direct |
| EGF/Laminin | 0.0003413 | Direct |
| Kringle-like | 0.002171 | Inherited |
| Growth factor receptor domain | 0.002446 | Inherited |
| Nuclear receptor ligand-binding domain | 0.002708 | Inherited |
| SH2 domain | 0.003528 | Inherited |
| HLH, helix-loop-helix DNA-binding domain | 0.01227 | Inherited |
| Metallothionein | 0.0139 | Inherited |
| Fibronectin type III | 0.01896 | Inherited |
| Cytochrome P450 | 0.01919 | Inherited |
| Protein kinase-like (PK-like) | 0.03379 | Inherited |
| MFS general substrate transporter | 0.03871 | Inherited |
| HD-domain/PDEase-like | 0.03993 | Inherited |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.04704 | Inherited |
| Integrin domains | 0.04811 | Inherited |
| TNF receptor-like | 0.04971 | Inherited |
| Thyroglobulin type-1 domain | 0.05725 | Inherited |
| DEATH domain | 0.06018 | Inherited |
| STAT | 0.102 | Inherited |
| Transcription factor STAT-4 N-domain | 0.102 | Inherited |
| Caspase-like | 0.1362 | Inherited |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.15 | Inherited |
| Immunoglobulin | 0.1553 | Inherited |
| Bcl-2 inhibitors of programmed cell death | 0.1772 | Inherited |
| Cyclin-like | 0.1865 | Inherited |
| NAD(P)-linked oxidoreductase | 0.1943 | Inherited |
| FYVE/PHD zinc finger | 0.2009 | Inherited |
| FAD/NAD(P)-binding domain | 0.2128 | Inherited |
| MHC antigen-recognition domain | 0.219 | Inherited |
| Flavoproteins | 0.2635 | Inherited |
| Inhibitor of apoptosis (IAP) repeat | 0.2664 | Inherited |
| E2F-DP heterodimerization region | 0.2664 | Inherited |
| NAD(P)-binding Rossmann-fold domains | 0.2794 | Inherited |
| (Phosphotyrosine protein) phosphatases II | 0.2818 | Inherited |
| Arginase/deacetylase | 0.3009 | Inherited |
| ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase | 0.3072 | Inherited |
| p53-like transcription factors | 0.3227 | Inherited |
| 14-3-3 protein | 0.3467 | Inherited |
| Metalloproteases ("zincins"), catalytic domain | 0.3623 | Inherited |
| Cystine-knot cytokines | 0.4274 | Inherited |
| "Winged helix" DNA-binding domain | 0.4481 | Inherited |
| ABC transporter transmembrane region | 0.465 | Inherited |
| Voltage-gated potassium channels | 0.562 | Inherited |
| Interleukin 8-like chemokines | 0.5846 | Inherited |
| SMAD/FHA domain | 0.5979 | Inherited |
| GST C-terminal domain-like | 0.6036 | Inherited |
| Lipocalins | 0.6451 | Inherited |
| S15/NS1 RNA-binding domain | 0.6494 | Inherited |
| TNF-like | 0.7812 | Inherited |
| 4-helical cytokines | 0.8996 | Inherited |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.9042 | Inherited |
| Nicotinic receptor ligand binding domain-like | 0.9042 | Inherited |
| UDP-Glycosyltransferase/glycogen phosphorylase | 0.9522 | Inherited |
| Thioredoxin-like | 1 | Inherited |
| Prefoldin | 1 | Inherited |
| Family A G protein-coupled receptor-like | 1 | Inherited |
| Intermediate filament protein, coiled coil region | 1 | Inherited |
LINKTO: Domain2BO Download and Domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Family( show details)
Highlighted in gray are those with FDR_all>0.001
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| alpha-ketoacid dehydrogenase kinase, N-terminal domain | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| Alkaline phosphatase | 0 | DIRECT |
| A20-like zinc finger | 0 | DIRECT |
| IP3 receptor type 1 binding core, domain 2 | 0 | DIRECT |
| 2'-5'-oligoadenylate synthetase 1, OAS1, second domain | 0 | DIRECT |
| Serine carboxypeptidase-like | 0 | DIRECT |
| MOSC N-terminal domain-like | 0 | DIRECT |
| DEATH effector domain, DED | 0 | DIRECT |
| 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, phosphatase domain | 0 | DIRECT |
| PAS domain of steroid receptor coactivator 1A, NCo-A1 | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| 2'-5'-oligoadenylate synthetase 1, OAS1, N-terminal domain | 0 | DIRECT |
| Platelet-derived growth factor-like | 0 | DIRECT |
| SMAD MH1 domain | 0 | DIRECT |
| Fibrinogen coiled-coil and central regions | 0 | DIRECT |
| Tetrahydrofolate dehydrogenase/cyclohydrolase | 0 | DIRECT |
| Alpha-adaptin ear subdomain-like | 0 | DIRECT |
| Prohormone convertase 1 pro-domain | 0 | DIRECT |
| alpha-ketoacid dehydrogenase kinase, C-terminal domain | 0 | DIRECT |
| Integrin beta tail domain | 0 | DIRECT |
| 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, kinase domain | 0 | DIRECT |
| p53 DNA-binding domain-like | 0 | DIRECT |
| RILP dimerisation region | 0 | DIRECT |
| CAT-like | 0 | DIRECT |
| Adenylyltransferase | 0 | DIRECT |
| Phoshatidylinositol transfer protein, PITP | 0 | DIRECT |
| Retinoblastoma tumor suppressor domains | 0 | DIRECT |
| Oligosaccharide phosphorylase | 0 | DIRECT |
| Nitric oxide (NO) synthase oxygenase domain | 0 | DIRECT |
| Hexokinase | 0 | DIRECT |
| Calnexin/calreticulin | 0 | DIRECT |
| Aminoacid dehydrogenase-like, C-terminal domain | 0 | DIRECT |
| N-terminal domain of cbl (N-cbl) | 0 | DIRECT |
| TB module/8-cys domain | 0 | DIRECT |
| BSD domain | 0 | DIRECT |
| Tissue inhibitor of metalloproteinases, TIMP | 0 | DIRECT |
| Integrin beta EGF-like domains | 0 | DIRECT |
| Cu,Zn superoxide dismutase-like | 0 | DIRECT |
| Clathrin adaptor appendage, alpha and beta chain-specific domain | 0 | DIRECT |
| Malic enzyme N-domain | 0 | DIRECT |
| Ubiquitin carboxyl-terminal hydrolase UCH-L | 0 | DIRECT |
| SMAD domain | 0 | DIRECT |
| Vasodilator-stimulated phosphoprotein, VASP, tetramerisation domain | 0 | DIRECT |
| HCDH C-domain-like | 0 | DIRECT |
| Leucine zipper domain | 0.00001751 | DIRECT |
| A DNA-binding domain in eukaryotic transcription factors | 0.00003905 | DIRECT |
| EGF-type module | 0.0004166 | DIRECT |
| Laminin G-like module | 0.0006513 | DIRECT |
| Growth factor receptor domain | 0.002015 | INHERITED FROM: Benzamides || Chloromercuribenzoates |
| Nuclear receptor ligand-binding domain | 0.002655 | INHERITED FROM: Bezafibrate || 4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid || Parabens || DEET || ethyl-p-hydroxybenzoate || fenpyroximate || 3-phenoxybenzoic acid || Chlorobenzoates || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || SR 11237 || Fenamates || isobutyl-4-hydroxybenzoate || Aminobenzoates || Hydroxybenzoates || benzylparaben || homosalate || isobutylparaben || Ro 41-5253 |
| SH2 domain | 0.003767 | INHERITED FROM: Imatinib Mesylate || tamibarotene |
| Nuclear receptor | 0.004802 | INHERITED FROM: Bezafibrate || 4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid || Parabens || ethyl-p-hydroxybenzoate || fenpyroximate || 3-phenoxybenzoic acid || Chlorobenzoates || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || SR 11237 || Fenamates || isobutyl-4-hydroxybenzoate || Aminobenzoates || Hydroxybenzoates || benzylparaben || homosalate || isobutylparaben || Ro 41-5253 |
| DEATH domain, DD | 0.01087 | INHERITED FROM: Parabens || Hydroxybenzoates |
| Metallothionein | 0.01255 | INHERITED FROM: Chlorobenzoates || Mercuribenzoates || Chloromercuribenzoates |
| HLH, helix-loop-helix DNA-binding domain | 0.01583 | INHERITED FROM: 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid || Benzocaine || butamben |
| Proprotein convertase P-domain | 0.02009 | INHERITED FROM: Aspirin |
| Fibronectin type III | 0.02167 | INHERITED FROM: Benzamides || 2-(oxalylamino)benzoic acid |
| Cytochrome P450 | 0.02402 | INHERITED FROM: Bezafibrate || DEET || 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide || GW 3965 || 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide || hexafluoron || Fenamates || 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid || Aminobenzoates || dimethocaine || triflumuron || Mefenamic Acid |
| PAPS sulfotransferase | 0.02803 | INHERITED FROM: DEET || Fenamates || ortho-Aminobenzoates |
| PDEase | 0.02857 | INHERITED FROM: Benzamides || Roflumilast |
| TNF receptor-like | 0.03939 | INHERITED FROM: Parabens || Aspirin || Hydroxybenzoates |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.04313 | INHERITED FROM: Chloromercuribenzoates |
| Ephrin receptor ligand binding domain | 0.05324 | INHERITED FROM: 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
| Thyroglobulin type-1 domain | 0.05367 | INHERITED FROM: Chloromercuribenzoates |
| Fatty acid binding protein-like | 0.0667 | INHERITED FROM: Bezafibrate |
| Protein kinases, catalytic subunit | 0.06991 | INHERITED FROM: Triiodobenzoic Acids || Imatinib Mesylate || AG-012986 || Iodobenzoates || tamibarotene || Hydroxybenzoates |
| STAT | 0.09363 | INHERITED FROM: Aspirin |
| Transcription factor STAT-4 N-domain | 0.09363 | INHERITED FROM: Aspirin |
| STAT DNA-binding domain | 0.09363 | INHERITED FROM: Aspirin |
| Long-chain cytokines | 0.1022 | INHERITED FROM: Aminobenzoates || Hydroxybenzoates |
| C1 set domains (antibody constant domain-like) | 0.1203 | INHERITED FROM: tamibarotene || entinostat |
| Phoshoinositide 3-kinase (PI3K), catalytic domain | 0.1276 | INHERITED FROM: Aspirin || butylparaben || Hydroxybenzoates |
| Cyclin | 0.1344 | INHERITED FROM: Parabens || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Hydroxybenzoates |
| C2 set domains | 0.1523 | INHERITED FROM: Aspirin || Salicylates || Hydroxybenzoates |
| Bcl-2 inhibitors of programmed cell death | 0.1667 | INHERITED FROM: Triiodobenzoic Acids || Parabens || Imatinib Mesylate || Hydrolyzable Tannins || Aspirin || atranorin || gyrophoric acid || Iodobenzoates || Fenamates || ortho-Aminobenzoates || BP-1-102 || Aminobenzoates || Hydroxybenzoates || propylparaben |
| Aldo-keto reductases (NADP) | 0.1838 | INHERITED FROM: fenamic acid || methyl salicylate || 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid || Fenamates || 4-hydroxybenzoic acid || Aminobenzoates || octyl gallate || Meclofenamic Acid || Hydroxybenzoates || Benzoic Acid || Flufenamic Acid |
| NADPH-cytochrome p450 reductase FAD-binding domain-like | 0.1877 | INHERITED FROM: Aspirin || Salicylates |
| NADPH-cytochrome p450 reductase-like | 0.1877 | INHERITED FROM: Aspirin || Salicylates |
| a tRNA synthase domain | 0.1957 | INHERITED FROM: C646 compound |
| MHC antigen-recognition domain | 0.2121 | INHERITED FROM: tamibarotene || entinostat |
| Caspase catalytic domain | 0.2151 | INHERITED FROM: Remoxipride || Parabens || Imatinib Mesylate || dehydroxymethylepoxyquinomicin || NCQ 344 || Fenamates || NCX 4040 || Aminobenzoates || Anacardic Acids || Hydroxybenzoates || propylparaben || Bromobenzoates || Niflumic Acid |
| Inhibitor of apoptosis (IAP) repeat | 0.2505 | INHERITED FROM: dehydroxymethylepoxyquinomicin || Anacardic Acids || Hydroxybenzoates |
| Histone deacetylase, HDAC | 0.2741 | INHERITED FROM: mocetinostat |
| ets domain | 0.2946 | INHERITED FROM: PD 0325901 |
| 14-3-3 protein | 0.3274 | INHERITED FROM: Aspirin |
| Cytochrome p450 reductase N-terminal domain-like | 0.3281 | INHERITED FROM: Aspirin |
| Cell cycle transcription factor e2f-dp | 0.3439 | INHERITED FROM: UF010 compound |
| ABC transporter transmembrane region | 0.3489 | INHERITED FROM: Bezafibrate || Imatinib Mesylate |
| E2F dimerization segment | 0.4238 | INHERITED FROM: UF010 compound |
| Glutathione S-transferase (GST), C-terminal domain | 0.4394 | INHERITED FROM: Fenamates || ortho-Aminobenzoates || Aminobenzoates |
| Higher-molecular-weight phosphotyrosine protein phosphatases | 0.4933 | INHERITED FROM: ortho-Aminobenzoates || Aminobenzoates || 2-(oxalylamino)benzoic acid |
| ABC transporter ATPase domain-like | 0.5576 | INHERITED FROM: Bezafibrate || Hippurates |
| Acetylcholinesterase-like | 0.5686 | INHERITED FROM: Aminobenzoates |
| Interleukin 8-like chemokines | 0.5749 | INHERITED FROM: sirtinol || Imatinib Mesylate || Hydrolyzable Tannins || Roflumilast || Hydroxybenzoates || roflumilast N-oxide |
| Voltage-gated potassium channels | 0.6072 | INHERITED FROM: Fenamates || ortho-Aminobenzoates || Niflumic Acid || Flufenamic Acid |
| Caspase recruitment domain, CARD | 0.6679 | INHERITED FROM: Parabens || propylparaben |
| Glutathione S-transferase (GST), N-terminal domain | 0.7418 | INHERITED FROM: Fenamates || ortho-Aminobenzoates || Mefenamic Acid |
| Tyrosine-dependent oxidoreductases | 0.7432 | INHERITED FROM: DEET |
| TNF-like | 0.7526 | INHERITED FROM: Bezafibrate |
| Nicotinic receptor ligand binding domain-like | 0.8763 | INHERITED FROM: 4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide || benzamide |
| Homeodomain | 0.8947 | INHERITED FROM: Mercuribenzoates || Chloromercuribenzoates |
| Interleukin-1 (IL-1) | 0.8977 | INHERITED FROM: Aspirin || ortho-Aminobenzoates || Salicylates || Aminobenzoates |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.9093 | INHERITED FROM: 4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide || benzamide |
| UDPGT-like | 0.9618 | INHERITED FROM: Diflunisal || Hydroxybenzoate Ethers || methyl salicylate || Salicylic Acid || Fenamates || ortho-Aminobenzoates || Aminobenzoates || Vanillic Acid || Hydroxybenzoates |
| Rhodopsin-like | 1 | INHERITED FROM: 1-(8-bromobenzo(1,2-b;4,5-b')difuran-4-yl)-2-aminopropane |
| Intermediate filament protein, coiled coil region | 1 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Nuclear receptor coactivator interlocking domain | 0 | Direct |
| alpha-ketoacid dehydrogenase kinase, N-terminal domain | 0 | Direct |
| p53 tetramerization domain | 0 | Direct |
| Alkaline phosphatase | 0 | Direct |
| A20-like zinc finger | 0 | Direct |
| IP3 receptor type 1 binding core, domain 2 | 0 | Direct |
| 2'-5'-oligoadenylate synthetase 1, OAS1, second domain | 0 | Direct |
| Serine carboxypeptidase-like | 0 | Direct |
| MOSC N-terminal domain-like | 0 | Direct |
| DEATH effector domain, DED | 0 | Direct |
| 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, phosphatase domain | 0 | Direct |
| PAS domain of steroid receptor coactivator 1A, NCo-A1 | 0 | Direct |
| P-domain of calnexin/calreticulin | 0 | Direct |
| 2'-5'-oligoadenylate synthetase 1, OAS1, N-terminal domain | 0 | Direct |
| Platelet-derived growth factor-like | 0 | Direct |
| SMAD MH1 domain | 0 | Direct |
| Fibrinogen coiled-coil and central regions | 0 | Direct |
| Tetrahydrofolate dehydrogenase/cyclohydrolase | 0 | Direct |
| Alpha-adaptin ear subdomain-like | 0 | Direct |
| Prohormone convertase 1 pro-domain | 0 | Direct |
| alpha-ketoacid dehydrogenase kinase, C-terminal domain | 0 | Direct |
| Integrin beta tail domain | 0 | Direct |
| 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, kinase domain | 0 | Direct |
| p53 DNA-binding domain-like | 0 | Direct |
| RILP dimerisation region | 0 | Direct |
| CAT-like | 0 | Direct |
| Adenylyltransferase | 0 | Direct |
| Phoshatidylinositol transfer protein, PITP | 0 | Direct |
| Retinoblastoma tumor suppressor domains | 0 | Direct |
| Oligosaccharide phosphorylase | 0 | Direct |
| Nitric oxide (NO) synthase oxygenase domain | 0 | Direct |
| Hexokinase | 0 | Direct |
| Calnexin/calreticulin | 0 | Direct |
| Aminoacid dehydrogenase-like, C-terminal domain | 0 | Direct |
| N-terminal domain of cbl (N-cbl) | 0 | Direct |
| TB module/8-cys domain | 0 | Direct |
| BSD domain | 0 | Direct |
| Tissue inhibitor of metalloproteinases, TIMP | 0 | Direct |
| Integrin beta EGF-like domains | 0 | Direct |
| Cu,Zn superoxide dismutase-like | 0 | Direct |
| Clathrin adaptor appendage, alpha and beta chain-specific domain | 0 | Direct |
| Malic enzyme N-domain | 0 | Direct |
| Ubiquitin carboxyl-terminal hydrolase UCH-L | 0 | Direct |
| SMAD domain | 0 | Direct |
| Vasodilator-stimulated phosphoprotein, VASP, tetramerisation domain | 0 | Direct |
| HCDH C-domain-like | 0 | Direct |
| Leucine zipper domain | 0.00001751 | Direct |
| A DNA-binding domain in eukaryotic transcription factors | 0.00003905 | Direct |
| EGF-type module | 0.0004166 | Direct |
| Laminin G-like module | 0.0006513 | Direct |
| Growth factor receptor domain | 0.002015 | Inherited |
| Nuclear receptor ligand-binding domain | 0.002655 | Inherited |
| SH2 domain | 0.003767 | Inherited |
| Nuclear receptor | 0.004802 | Inherited |
| DEATH domain, DD | 0.01087 | Inherited |
| Metallothionein | 0.01255 | Inherited |
| HLH, helix-loop-helix DNA-binding domain | 0.01583 | Inherited |
| Proprotein convertase P-domain | 0.02009 | Inherited |
| Fibronectin type III | 0.02167 | Inherited |
| Cytochrome P450 | 0.02402 | Inherited |
| PAPS sulfotransferase | 0.02803 | Inherited |
| PDEase | 0.02857 | Inherited |
| TNF receptor-like | 0.03939 | Inherited |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.04313 | Inherited |
| Ephrin receptor ligand binding domain | 0.05324 | Inherited |
| Thyroglobulin type-1 domain | 0.05367 | Inherited |
| Fatty acid binding protein-like | 0.0667 | Inherited |
| Protein kinases, catalytic subunit | 0.06991 | Inherited |
| STAT | 0.09363 | Inherited |
| Transcription factor STAT-4 N-domain | 0.09363 | Inherited |
| STAT DNA-binding domain | 0.09363 | Inherited |
| Long-chain cytokines | 0.1022 | Inherited |
| C1 set domains (antibody constant domain-like) | 0.1203 | Inherited |
| Phoshoinositide 3-kinase (PI3K), catalytic domain | 0.1276 | Inherited |
| Cyclin | 0.1344 | Inherited |
| C2 set domains | 0.1523 | Inherited |
| Bcl-2 inhibitors of programmed cell death | 0.1667 | Inherited |
| Aldo-keto reductases (NADP) | 0.1838 | Inherited |
| NADPH-cytochrome p450 reductase FAD-binding domain-like | 0.1877 | Inherited |
| NADPH-cytochrome p450 reductase-like | 0.1877 | Inherited |
| a tRNA synthase domain | 0.1957 | Inherited |
| MHC antigen-recognition domain | 0.2121 | Inherited |
| Caspase catalytic domain | 0.2151 | Inherited |
| Inhibitor of apoptosis (IAP) repeat | 0.2505 | Inherited |
| Histone deacetylase, HDAC | 0.2741 | Inherited |
| ets domain | 0.2946 | Inherited |
| 14-3-3 protein | 0.3274 | Inherited |
| Cytochrome p450 reductase N-terminal domain-like | 0.3281 | Inherited |
| Cell cycle transcription factor e2f-dp | 0.3439 | Inherited |
| ABC transporter transmembrane region | 0.3489 | Inherited |
| E2F dimerization segment | 0.4238 | Inherited |
| Glutathione S-transferase (GST), C-terminal domain | 0.4394 | Inherited |
| Higher-molecular-weight phosphotyrosine protein phosphatases | 0.4933 | Inherited |
| ABC transporter ATPase domain-like | 0.5576 | Inherited |
| Acetylcholinesterase-like | 0.5686 | Inherited |
| Interleukin 8-like chemokines | 0.5749 | Inherited |
| Voltage-gated potassium channels | 0.6072 | Inherited |
| Caspase recruitment domain, CARD | 0.6679 | Inherited |
| Glutathione S-transferase (GST), N-terminal domain | 0.7418 | Inherited |
| Tyrosine-dependent oxidoreductases | 0.7432 | Inherited |
| TNF-like | 0.7526 | Inherited |
| Nicotinic receptor ligand binding domain-like | 0.8763 | Inherited |
| Homeodomain | 0.8947 | Inherited |
| Interleukin-1 (IL-1) | 0.8977 | Inherited |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.9093 | Inherited |
| UDPGT-like | 0.9618 | Inherited |
| Rhodopsin-like | 1 | Inherited |
| Intermediate filament protein, coiled coil region | 1 | Inherited |
LINKTO: Domain2BO Download and Domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Single)( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Single) |
FDR (all) |
Annotation (direct or inherited) |
| Integrin beta tail domain | 0 | DIRECT |
| SMAD MH1 domain | 0 | DIRECT |
| Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| Nitric oxide (NO) synthase oxygenase domain | 0 | DIRECT |
| beta-lactamase/transpeptidase-like | 0 | DIRECT |
| N-terminal domain of cbl (N-cbl) | 0 | DIRECT |
| BSD domain-like | 0 | DIRECT |
| FAD-linked oxidases, C-terminal domain | 0 | DIRECT |
| RILP dimerisation region | 0 | DIRECT |
| Aminoacid dehydrogenase-like, N-terminal domain | 0 | DIRECT |
| AhpD-like | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| Cu,Zn superoxide dismutase-like | 0 | DIRECT |
| Vasodilator-stimulated phosphoprotein, VASP, tetramerisation domain | 0 | DIRECT |
| Nicotinate/Quinolinate PRTase C-terminal domain-like | 0 | DIRECT |
| alpha-ketoacid dehydrogenase kinase, N-terminal domain | 0 | DIRECT |
| Fibrinogen coiled-coil and central regions | 0 | DIRECT |
| MOSC N-terminal domain-like | 0 | DIRECT |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| TB module/8-cys domain | 0 | DIRECT |
| Leucine zipper domain | 0.000009196 | DIRECT |
| A DNA-binding domain in eukaryotic transcription factors | 0.00002134 | DIRECT |
| PYP-like sensor domain (PAS domain) | 0.0001294 | DIRECT |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.0001776 | DIRECT |
| EGF/Laminin | 0.0001931 | DIRECT |
| Kringle-like | 0.001348 | INHERITED FROM: Hydroxybenzoates || Aspirin |
| Growth factor receptor domain | 0.001527 | INHERITED FROM: Chloromercuribenzoates || Benzamides |
| Nuclear receptor ligand-binding domain | 0.001701 | INHERITED FROM: 4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid || homosalate || 3-phenoxybenzoic acid || Ro 41-5253 || ethyl-p-hydroxybenzoate || SR 11237 || Fenamates || Hydroxybenzoates || Bezafibrate || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || fenpyroximate || Aminobenzoates || Chlorobenzoates || DEET || Parabens || benzylparaben || isobutylparaben || isobutyl-4-hydroxybenzoate |
| SH2 domain | 0.002244 | INHERITED FROM: tamibarotene || Imatinib Mesylate |
| HLH, helix-loop-helix DNA-binding domain | 0.008365 | INHERITED FROM: Benzocaine || butamben || Chlorobenzoates || 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid |
| Metallothionein | 0.009544 | INHERITED FROM: Chloromercuribenzoates || Chlorobenzoates || Mercuribenzoates |
| Fibronectin type III | 0.01328 | INHERITED FROM: 2-(oxalylamino)benzoic acid || Benzamides |
| Cytochrome P450 | 0.01345 | INHERITED FROM: triflumuron || Fenamates || Bezafibrate || hexafluoron || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Aminobenzoates || 4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide || 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide || 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid || DEET || dimethocaine || GW 3965 |
| HMG-box | 0.02208 | INHERITED FROM: methylparaben |
| Protein kinase-like (PK-like) | 0.02446 | INHERITED FROM: AG-012986 || Hydroxybenzoates || 2''-galloylhyperin || N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide || Triiodobenzoic Acids || Iodobenzoates || tamibarotene || 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide || Imatinib Mesylate |
| MFS general substrate transporter | 0.02822 | INHERITED FROM: Fenamates || Bumetanide || Aminohippuric Acids || Sulpiride || Aminobenzoates || p-Aminohippuric Acid || 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid || Salicylic Acid || Hippurates |
| HD-domain/PDEase-like | 0.02917 | INHERITED FROM: Roflumilast || Benzamides |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.03469 | INHERITED FROM: Chloromercuribenzoates |
| Integrin domains | 0.03555 | INHERITED FROM: Salicylates |
| TNF receptor-like | 0.03682 | INHERITED FROM: Hydroxybenzoates || Aspirin || Parabens |
| FnI-like domain | 0.04102 | INHERITED FROM: Benzamides |
| Thyroglobulin type-1 domain | 0.04266 | INHERITED FROM: Chloromercuribenzoates |
| DEATH domain | 0.04496 | INHERITED FROM: Hydroxybenzoates || propylparaben || Parabens || dehydroxymethylepoxyquinomicin || Imatinib Mesylate || Anacardic Acids |
| TSP-1 type 1 repeat | 0.0761 | INHERITED FROM: Chloromercuribenzoates || Benzamides |
| Transcription factor STAT-4 N-domain | 0.07854 | INHERITED FROM: Aspirin || Salicylates |
| STAT | 0.07854 | INHERITED FROM: Aspirin || Salicylates |
| Caspase-like | 0.1065 | INHERITED FROM: NCX 4040 || NCQ 344 || Fenamates || Hydroxybenzoates || Remoxipride || propylparaben || Aminobenzoates || Parabens || Niflumic Acid || dehydroxymethylepoxyquinomicin || 3-bromoacetylamino benzoic acid ethyl ester || Bromobenzoates || Imatinib Mesylate || Anacardic Acids |
| PAP/OAS1 substrate-binding domain | 0.1147 | INHERITED FROM: tamibarotene |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.1181 | INHERITED FROM: Chloromercuribenzoates |
| Immunoglobulin | 0.1224 | INHERITED FROM: HX 630 |
| Bcl-2 inhibitors of programmed cell death | 0.141 | INHERITED FROM: BP-1-102 || Fenamates || Hydroxybenzoates || Hydrolyzable Tannins || propylparaben || Aminobenzoates || gyrophoric acid || atranorin || Aspirin || Triiodobenzoic Acids || Parabens || Iodobenzoates || ortho-Aminobenzoates || Imatinib Mesylate |
| Cyclin-like | 0.1489 | INHERITED FROM: Ro 41-5253 || Hydroxybenzoates || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Parabens || UF010 compound |
| NAD(P)-linked oxidoreductase | 0.1557 | INHERITED FROM: fenamic acid || Fenamates || Benzoic Acid || Hydroxybenzoates || 4-hydroxybenzoic acid || Aminobenzoates || methyl salicylate || octyl gallate || Meclofenamic Acid || 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid || Flufenamic Acid |
| FYVE/PHD zinc finger | 0.1614 | INHERITED FROM: 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
| FAD/NAD(P)-binding domain | 0.1717 | INHERITED FROM: Nitrobenzoates |
| MHC antigen-recognition domain | 0.177 | INHERITED FROM: tamibarotene || entinostat |
| Flavoproteins | 0.2159 | INHERITED FROM: Fenamates || Benzoic Acid || Hydroxybenzoates || Aminobenzoates || Aspirin || ortho-Aminobenzoates || Salicylates |
| E2F-DP heterodimerization region | 0.2184 | INHERITED FROM: UF010 compound |
| Inhibitor of apoptosis (IAP) repeat | 0.2184 | INHERITED FROM: Hydroxybenzoates || dehydroxymethylepoxyquinomicin || Anacardic Acids |
| NAD(P)-binding Rossmann-fold domains | 0.2298 | INHERITED FROM: methyl salicylate || DEET |
| (Phosphotyrosine protein) phosphatases II | 0.2319 | INHERITED FROM: Aminobenzoates || anthranilic acid || ortho-Aminobenzoates || 2-(oxalylamino)benzoic acid |
| Arginase/deacetylase | 0.2487 | INHERITED FROM: mocetinostat |
| ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase | 0.2545 | INHERITED FROM: VER-246608 || tamibarotene |
| p53-like transcription factors | 0.2687 | INHERITED FROM: Iopamidol || Triiodobenzoic Acids || Iodobenzoates || Salicylates || Imatinib Mesylate || Anacardic Acids |
| 14-3-3 protein | 0.2906 | INHERITED FROM: Aspirin || Salicylates |
| Metalloproteases ("zincins"), catalytic domain | 0.3047 | INHERITED FROM: PD 0325901 |
| Cytokine | 0.3374 | INHERITED FROM: ortho-Aminobenzoates |
| Cystine-knot cytokines | 0.3645 | INHERITED FROM: MOPP protocol || Procarbazine |
| "Winged helix" DNA-binding domain | 0.3838 | INHERITED FROM: UF010 compound |
| ABC transporter transmembrane region | 0.3994 | INHERITED FROM: Bezafibrate || Imatinib Mesylate |
| EF-hand | 0.4426 | INHERITED FROM: entinostat |
| Homeodomain-like | 0.4527 | INHERITED FROM: Chloromercuribenzoates || Mercuribenzoates |
| Voltage-gated potassium channels | 0.4915 | INHERITED FROM: Niflumic Acid || Flufenamic Acid |
| Interleukin 8-like chemokines | 0.5137 | INHERITED FROM: Roflumilast || roflumilast N-oxide || Hydroxybenzoates || Hydrolyzable Tannins || sirtinol || Imatinib Mesylate |
| SMAD/FHA domain | 0.5266 | INHERITED FROM: sirtinol |
| GST C-terminal domain-like | 0.5323 | INHERITED FROM: Fenamates || Aminobenzoates || ortho-Aminobenzoates |
| Lipocalins | 0.5735 | INHERITED FROM: Bezafibrate |
| S15/NS1 RNA-binding domain | 0.5777 | INHERITED FROM: C646 compound |
| TNF-like | 0.7111 | INHERITED FROM: Bezafibrate |
| 4-helical cytokines | 0.8367 | INHERITED FROM: Sodium Salicylate || Ro 41-5253 || Hydroxybenzoates || Aminobenzoates || FK 706 |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.8414 | INHERITED FROM: 4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide || benzamide |
| Nicotinic receptor ligand binding domain-like | 0.8414 | INHERITED FROM: 4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide || benzamide |
| UDP-Glycosyltransferase/glycogen phosphorylase | 0.8939 | INHERITED FROM: Fenamates || Diflunisal || Aminobenzoates || Hydroxybenzoate Ethers || methyl salicylate || Salicylic Acid || ortho-Aminobenzoates || Vanillic Acid |
| Intermediate filament protein, coiled coil region | 0.9668 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
| Thioredoxin-like | 0.9698 | INHERITED FROM: Fenamates || ortho-Aminobenzoates |
| Prefoldin | 0.98 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
| Ribosomal protein S5 domain 2-like | 0.9893 | INHERITED FROM: tamibarotene |
| Family A G protein-coupled receptor-like | 1 | INHERITED FROM: 1-(8-bromobenzo(1,2-b;4,5-b')difuran-4-yl)-2-aminopropane |
| Supra-domain (Single) |
FDR (all) |
Annotation (direct or inherited) |
| Integrin beta tail domain | 0 | Direct |
| SMAD MH1 domain | 0 | Direct |
| Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex | 0 | Direct |
| P-domain of calnexin/calreticulin | 0 | Direct |
| Nitric oxide (NO) synthase oxygenase domain | 0 | Direct |
| beta-lactamase/transpeptidase-like | 0 | Direct |
| N-terminal domain of cbl (N-cbl) | 0 | Direct |
| BSD domain-like | 0 | Direct |
| FAD-linked oxidases, C-terminal domain | 0 | Direct |
| RILP dimerisation region | 0 | Direct |
| Aminoacid dehydrogenase-like, N-terminal domain | 0 | Direct |
| AhpD-like | 0 | Direct |
| p53 tetramerization domain | 0 | Direct |
| Cu,Zn superoxide dismutase-like | 0 | Direct |
| Vasodilator-stimulated phosphoprotein, VASP, tetramerisation domain | 0 | Direct |
| Nicotinate/Quinolinate PRTase C-terminal domain-like | 0 | Direct |
| alpha-ketoacid dehydrogenase kinase, N-terminal domain | 0 | Direct |
| Fibrinogen coiled-coil and central regions | 0 | Direct |
| MOSC N-terminal domain-like | 0 | Direct |
| Nuclear receptor coactivator interlocking domain | 0 | Direct |
| TB module/8-cys domain | 0 | Direct |
| Leucine zipper domain | 0.000009196 | Direct |
| A DNA-binding domain in eukaryotic transcription factors | 0.00002134 | Direct |
| PYP-like sensor domain (PAS domain) | 0.0001294 | Direct |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.0001776 | Direct |
| EGF/Laminin | 0.0001931 | Direct |
| Kringle-like | 0.001348 | Inherited |
| Growth factor receptor domain | 0.001527 | Inherited |
| Nuclear receptor ligand-binding domain | 0.001701 | Inherited |
| SH2 domain | 0.002244 | Inherited |
| HLH, helix-loop-helix DNA-binding domain | 0.008365 | Inherited |
| Metallothionein | 0.009544 | Inherited |
| Fibronectin type III | 0.01328 | Inherited |
| Cytochrome P450 | 0.01345 | Inherited |
| HMG-box | 0.02208 | Inherited |
| Protein kinase-like (PK-like) | 0.02446 | Inherited |
| MFS general substrate transporter | 0.02822 | Inherited |
| HD-domain/PDEase-like | 0.02917 | Inherited |
| Heat shock protein 70kD (HSP70), C-terminal subdomain | 0.03469 | Inherited |
| Integrin domains | 0.03555 | Inherited |
| TNF receptor-like | 0.03682 | Inherited |
| FnI-like domain | 0.04102 | Inherited |
| Thyroglobulin type-1 domain | 0.04266 | Inherited |
| DEATH domain | 0.04496 | Inherited |
| TSP-1 type 1 repeat | 0.0761 | Inherited |
| Transcription factor STAT-4 N-domain | 0.07854 | Inherited |
| STAT | 0.07854 | Inherited |
| Caspase-like | 0.1065 | Inherited |
| PAP/OAS1 substrate-binding domain | 0.1147 | Inherited |
| Heat shock protein 70kD (HSP70), peptide-binding domain | 0.1181 | Inherited |
| Immunoglobulin | 0.1224 | Inherited |
| Bcl-2 inhibitors of programmed cell death | 0.141 | Inherited |
| Cyclin-like | 0.1489 | Inherited |
| NAD(P)-linked oxidoreductase | 0.1557 | Inherited |
| FYVE/PHD zinc finger | 0.1614 | Inherited |
| FAD/NAD(P)-binding domain | 0.1717 | Inherited |
| MHC antigen-recognition domain | 0.177 | Inherited |
| Flavoproteins | 0.2159 | Inherited |
| E2F-DP heterodimerization region | 0.2184 | Inherited |
| Inhibitor of apoptosis (IAP) repeat | 0.2184 | Inherited |
| NAD(P)-binding Rossmann-fold domains | 0.2298 | Inherited |
| (Phosphotyrosine protein) phosphatases II | 0.2319 | Inherited |
| Arginase/deacetylase | 0.2487 | Inherited |
| ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase | 0.2545 | Inherited |
| p53-like transcription factors | 0.2687 | Inherited |
| 14-3-3 protein | 0.2906 | Inherited |
| Metalloproteases ("zincins"), catalytic domain | 0.3047 | Inherited |
| Cytokine | 0.3374 | Inherited |
| Cystine-knot cytokines | 0.3645 | Inherited |
| "Winged helix" DNA-binding domain | 0.3838 | Inherited |
| ABC transporter transmembrane region | 0.3994 | Inherited |
| EF-hand | 0.4426 | Inherited |
| Homeodomain-like | 0.4527 | Inherited |
| Voltage-gated potassium channels | 0.4915 | Inherited |
| Interleukin 8-like chemokines | 0.5137 | Inherited |
| SMAD/FHA domain | 0.5266 | Inherited |
| GST C-terminal domain-like | 0.5323 | Inherited |
| Lipocalins | 0.5735 | Inherited |
| S15/NS1 RNA-binding domain | 0.5777 | Inherited |
| TNF-like | 0.7111 | Inherited |
| 4-helical cytokines | 0.8367 | Inherited |
| Neurotransmitter-gated ion-channel transmembrane pore | 0.8414 | Inherited |
| Nicotinic receptor ligand binding domain-like | 0.8414 | Inherited |
| UDP-Glycosyltransferase/glycogen phosphorylase | 0.8939 | Inherited |
| Intermediate filament protein, coiled coil region | 0.9668 | Inherited |
| Thioredoxin-like | 0.9698 | Inherited |
| Prefoldin | 0.98 | Inherited |
| Ribosomal protein S5 domain 2-like | 0.9893 | Inherited |
| Family A G protein-coupled receptor-like | 1 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Duplex) in N- to C-terminal order( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
52540,53254 52540 - P-loop containing nucleoside triphosphate hydrolases 53254 - Phosphoglycerate mutase-like | 0 | DIRECT |
46785,158702 46785 - "Winged helix" DNA-binding domain 158702 - Sec63 N-terminal domain-like | 0 | DIRECT |
50729,46785 50729 - PH domain-like 46785 - "Winged helix" DNA-binding domain | 0 | DIRECT |
141673,50800 141673 - MOSC N-terminal domain-like 50800 - PK beta-barrel domain-like | 0 | DIRECT |
56176,55103 56176 - FAD-binding/transporter-associated domain-like 55103 - FAD-linked oxidases, C-terminal domain | 0 | DIRECT |
48350,50044 48350 - GTPase activation domain, GAP 50044 - SH3-domain | 0 | DIRECT |
51230,47005 51230 - Single hybrid motif 47005 - Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex | 0 | DIRECT |
57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat | 0 | DIRECT |
57581,57184 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain | 0 | DIRECT |
69012,55874 69012 - alpha-ketoacid dehydrogenase kinase, N-terminal domain 55874 - ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase | 0 | DIRECT |
47473,57610 47473 - EF-hand 57610 - Thyroglobulin type-1 domain | 0 | DIRECT |
63501,50242 63501 - Frizzled cysteine-rich domain 50242 - TIMP-like | 0 | DIRECT |
81324,53850 81324 - Voltage-gated potassium channels 53850 - Periplasmic binding protein-like II | 0 | DIRECT |
74924,74924 74924 - Cap-Gly domain 74924 - Cap-Gly domain | 0 | DIRECT |
47005,52777 47005 - Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex 52777 - CoA-dependent acyltransferases | 0 | DIRECT |
47473,55550 47473 - EF-hand 55550 - SH2 domain | 0 | DIRECT |
53300,49899 53300 - vWA-like 49899 - Concanavalin A-like lectins/glucanases | 0 | DIRECT |
57184,57581 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain | 0 | DIRECT |
57184,57184 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain | 0 | DIRECT |
49562,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain | 0 | DIRECT |
100895,50494 100895 - Kazal-type serine protease inhibitors 50494 - Trypsin-like serine proteases | 0 | DIRECT |
47668,47473 47668 - N-terminal domain of cbl (N-cbl) 47473 - EF-hand | 0 | DIRECT |
57581,57196 57581 - TB module/8-cys domain 57196 - EGF/Laminin | 0 | DIRECT |
56112,56112 56112 - Protein kinase-like (PK-like) 56112 - Protein kinase-like (PK-like) | 0 | DIRECT |
53300,69179 53300 - vWA-like 69179 - Integrin domains | 0 | DIRECT |
48726,82895 48726 - Immunoglobulin 82895 - TSP-1 type 1 repeat | 0 | DIRECT |
53223,51735 53223 - Aminoacid dehydrogenase-like, N-terminal domain 51735 - NAD(P)-binding Rossmann-fold domains | 0 | DIRECT |
57414,57440 57414 - Hairpin loop containing domain-like 57440 - Kringle-like | 0 | DIRECT |
49695,50370 49695 - gamma-Crystallin-like 50370 - Ricin B-like lectins | 0 | DIRECT |
57196,69687 57196 - EGF/Laminin 69687 - Integrin beta tail domain | 0 | DIRECT |
117839,56399 117839 - WWE domain 56399 - ADP-ribosylation | 0 | DIRECT |
51905,47576 51905 - FAD/NAD(P)-binding domain 47576 - Calponin-homology domain, CH-domain | 0 | DIRECT |
57196,90193 57196 - EGF/Laminin 90193 - Notch domain | 0 | DIRECT |
57196,57581 57196 - EGF/Laminin 57581 - TB module/8-cys domain | 0 | DIRECT |
55550,57850 55550 - SH2 domain 57850 - RING/U-box | 0 | DIRECT |
53300,49265 53300 - vWA-like 49265 - Fibronectin type III | 0 | DIRECT |
100934,100934 100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain 100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain | 0 | DIRECT |
57581,57581 57581 - TB module/8-cys domain 57581 - TB module/8-cys domain | 0 | DIRECT |
49899,63887 49899 - Concanavalin A-like lectins/glucanases 63887 - P-domain of calnexin/calreticulin | 0 | DIRECT |
54826,51604 54826 - Enolase N-terminal domain-like 51604 - Enolase C-terminal domain-like | 0 | DIRECT |
49417,47719 49417 - p53-like transcription factors 47719 - p53 tetramerization domain | 0 | DIRECT |
47454,57959 47454 - A DNA-binding domain in eukaryotic transcription factors 57959 - Leucine zipper domain | 0.00004537 | DIRECT |
82895,82895 82895 - TSP-1 type 1 repeat 82895 - TSP-1 type 1 repeat | 0.00009272 | DIRECT |
57196,57196 57196 - EGF/Laminin 57196 - EGF/Laminin | 0.0001158 | DIRECT |
57716,48508 57716 - Glucocorticoid receptor-like (DNA-binding domain) 48508 - Nuclear receptor ligand-binding domain | 0.0007347 | DIRECT |
54897,52743 54897 - Protease propeptides/inhibitors 52743 - Subtilisin-like | 0.003763 | INHERITED FROM: Aspirin |
55785,55785 55785 - PYP-like sensor domain (PAS domain) 55785 - PYP-like sensor domain (PAS domain) | 0.003763 | INHERITED FROM: para-Aminobenzoates || Benzocaine || butamben || Hydroxybenzoates || Aminobenzoates |
57184,49899 57184 - Growth factor receptor domain 49899 - Concanavalin A-like lectins/glucanases | 0.003763 | INHERITED FROM: 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide || Benzamides |
57716,57716 57716 - Glucocorticoid receptor-like (DNA-binding domain) 57716 - Glucocorticoid receptor-like (DNA-binding domain) | 0.007528 | INHERITED FROM: Benzamides |
57440,57440 57440 - Kringle-like 57440 - Kringle-like | 0.009971 | INHERITED FROM: Hydroxybenzoates || Aspirin |
57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like | 0.01406 | INHERITED FROM: Hydroxybenzoates || Aspirin || Parabens |
47459,55785 47459 - HLH, helix-loop-helix DNA-binding domain 55785 - PYP-like sensor domain (PAS domain) | 0.01406 | INHERITED FROM: Benzocaine || butamben || Hydroxybenzoates || Aminobenzoates |
52743,49785 52743 - Subtilisin-like 49785 - Galactose-binding domain-like | 0.01515 | INHERITED FROM: Aspirin || Salicylates |
57440,50494 57440 - Kringle-like 50494 - Trypsin-like serine proteases | 0.03265 | INHERITED FROM: Aspirin |
56112,47769 56112 - Protein kinase-like (PK-like) 47769 - SAM/Pointed domain | 0.04272 | INHERITED FROM: 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
52821,52799 52821 - Rhodanese/Cell cycle control phosphatase 52799 - (Phosphotyrosine protein) phosphatases II | 0.04923 | INHERITED FROM: Chloromercuribenzoates |
57184,49265 57184 - Growth factor receptor domain 49265 - Fibronectin type III | 0.05647 | INHERITED FROM: Chloromercuribenzoates || Chlorobenzoates || Mercuribenzoates |
57184,57196 57184 - Growth factor receptor domain 57196 - EGF/Laminin | 0.06188 | INHERITED FROM: entinostat |
54452,48726 54452 - MHC antigen-recognition domain 48726 - Immunoglobulin | 0.0685 | INHERITED FROM: tamibarotene || entinostat |
47655,49417 47655 - STAT 49417 - p53-like transcription factors | 0.07854 | INHERITED FROM: Aspirin || Salicylates |
48092,47655 48092 - Transcription factor STAT-4 N-domain 47655 - STAT | 0.07854 | INHERITED FROM: Aspirin || Salicylates |
49417,55550 49417 - p53-like transcription factors 55550 - SH2 domain | 0.07854 | INHERITED FROM: Aspirin || Salicylates |
47986,47986 47986 - DEATH domain 47986 - DEATH domain | 0.07854 | INHERITED FROM: Hydroxybenzoates || Aspirin |
55550,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.08021 | INHERITED FROM: Hydroxybenzoates || Aspirin || tamibarotene || Imatinib Mesylate |
81301,81631 81301 - Nucleotidyltransferase 81631 - PAP/OAS1 substrate-binding domain | 0.1147 | INHERITED FROM: tamibarotene |
56436,57535 56436 - C-type lectin-like 57535 - Complement control module/SCR domain | 0.1164 | INHERITED FROM: Chlorobenzoates |
53067,100920 53067 - Actin-like ATPase domain 100920 - Heat shock protein 70kD (HSP70), peptide-binding domain | 0.1181 | INHERITED FROM: Chloromercuribenzoates |
47986,52129 47986 - DEATH domain 52129 - Caspase-like | 0.1612 | INHERITED FROM: NCX 4040 || Hydroxybenzoates || propylparaben || Aminobenzoates || Parabens || dehydroxymethylepoxyquinomicin || Imatinib Mesylate || Anacardic Acids |
46785,144074 46785 - "Winged helix" DNA-binding domain 144074 - E2F-DP heterodimerization region | 0.2184 | INHERITED FROM: UF010 compound |
81324,81324 81324 - Voltage-gated potassium channels 81324 - Voltage-gated potassium channels | 0.2439 | INHERITED FROM: Mefenamic Acid || Fenamates || Aminobenzoates || Niflumic Acid || ortho-Aminobenzoates || Flufenamic Acid |
52799,52799 52799 - (Phosphotyrosine protein) phosphatases II 52799 - (Phosphotyrosine protein) phosphatases II | 0.2487 | INHERITED FROM: Aminobenzoates || ortho-Aminobenzoates || 2-(oxalylamino)benzoic acid |
49562,48371 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 48371 - ARM repeat | 0.2906 | INHERITED FROM: tamibarotene |
50044,55550 50044 - SH3-domain 55550 - SH2 domain | 0.3456 | INHERITED FROM: tamibarotene || Imatinib Mesylate |
47954,47954 47954 - Cyclin-like 47954 - Cyclin-like | 0.3994 | INHERITED FROM: Hydroxybenzoates || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Aspirin || Parabens |
90123,52540 90123 - ABC transporter transmembrane region 52540 - P-loop containing nucleoside triphosphate hydrolases | 0.3994 | INHERITED FROM: Bezafibrate || Imatinib Mesylate |
52833,47616 52833 - Thioredoxin-like 47616 - GST C-terminal domain-like | 0.538 | INHERITED FROM: Fenamates || Aminobenzoates || ortho-Aminobenzoates |
46579,64593 46579 - Prefoldin 64593 - Intermediate filament protein, coiled coil region | 0.6385 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
52540,90123 52540 - P-loop containing nucleoside triphosphate hydrolases 90123 - ABC transporter transmembrane region | 0.735 | INHERITED FROM: Aspirin |
63712,90112 63712 - Nicotinic receptor ligand binding domain-like 90112 - Neurotransmitter-gated ion-channel transmembrane pore | 0.8414 | INHERITED FROM: 4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide || benzamide |
64593,64593 64593 - Intermediate filament protein, coiled coil region 64593 - Intermediate filament protein, coiled coil region | 0.9846 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid |
| Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
52540,53254 52540 - P-loop containing nucleoside triphosphate hydrolases 53254 - Phosphoglycerate mutase-like | 0 | Direct |
46785,158702 46785 - "Winged helix" DNA-binding domain 158702 - Sec63 N-terminal domain-like | 0 | Direct |
50729,46785 50729 - PH domain-like 46785 - "Winged helix" DNA-binding domain | 0 | Direct |
141673,50800 141673 - MOSC N-terminal domain-like 50800 - PK beta-barrel domain-like | 0 | Direct |
56176,55103 56176 - FAD-binding/transporter-associated domain-like 55103 - FAD-linked oxidases, C-terminal domain | 0 | Direct |
48350,50044 48350 - GTPase activation domain, GAP 50044 - SH3-domain | 0 | Direct |
51230,47005 51230 - Single hybrid motif 47005 - Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex | 0 | Direct |
57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat | 0 | Direct |
57581,57184 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain | 0 | Direct |
69012,55874 69012 - alpha-ketoacid dehydrogenase kinase, N-terminal domain 55874 - ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase | 0 | Direct |
47473,57610 47473 - EF-hand 57610 - Thyroglobulin type-1 domain | 0 | Direct |
63501,50242 63501 - Frizzled cysteine-rich domain 50242 - TIMP-like | 0 | Direct |
81324,53850 81324 - Voltage-gated potassium channels 53850 - Periplasmic binding protein-like II | 0 | Direct |
74924,74924 74924 - Cap-Gly domain 74924 - Cap-Gly domain | 0 | Direct |
47005,52777 47005 - Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex 52777 - CoA-dependent acyltransferases | 0 | Direct |
47473,55550 47473 - EF-hand 55550 - SH2 domain | 0 | Direct |
53300,49899 53300 - vWA-like 49899 - Concanavalin A-like lectins/glucanases | 0 | Direct |
57184,57581 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain | 0 | Direct |
57184,57184 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain | 0 | Direct |
49562,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain | 0 | Direct |
100895,50494 100895 - Kazal-type serine protease inhibitors 50494 - Trypsin-like serine proteases | 0 | Direct |
47668,47473 47668 - N-terminal domain of cbl (N-cbl) 47473 - EF-hand | 0 | Direct |
57581,57196 57581 - TB module/8-cys domain 57196 - EGF/Laminin | 0 | Direct |
56112,56112 56112 - Protein kinase-like (PK-like) 56112 - Protein kinase-like (PK-like) | 0 | Direct |
53300,69179 53300 - vWA-like 69179 - Integrin domains | 0 | Direct |
48726,82895 48726 - Immunoglobulin 82895 - TSP-1 type 1 repeat | 0 | Direct |
53223,51735 53223 - Aminoacid dehydrogenase-like, N-terminal domain 51735 - NAD(P)-binding Rossmann-fold domains | 0 | Direct |
57414,57440 57414 - Hairpin loop containing domain-like 57440 - Kringle-like | 0 | Direct |
49695,50370 49695 - gamma-Crystallin-like 50370 - Ricin B-like lectins | 0 | Direct |
57196,69687 57196 - EGF/Laminin 69687 - Integrin beta tail domain | 0 | Direct |
117839,56399 117839 - WWE domain 56399 - ADP-ribosylation | 0 | Direct |
51905,47576 51905 - FAD/NAD(P)-binding domain 47576 - Calponin-homology domain, CH-domain | 0 | Direct |
57196,90193 57196 - EGF/Laminin 90193 - Notch domain | 0 | Direct |
57196,57581 57196 - EGF/Laminin 57581 - TB module/8-cys domain | 0 | Direct |
55550,57850 55550 - SH2 domain 57850 - RING/U-box | 0 | Direct |
53300,49265 53300 - vWA-like 49265 - Fibronectin type III | 0 | Direct |
100934,100934 100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain 100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain | 0 | Direct |
57581,57581 57581 - TB module/8-cys domain 57581 - TB module/8-cys domain | 0 | Direct |
49899,63887 49899 - Concanavalin A-like lectins/glucanases 63887 - P-domain of calnexin/calreticulin | 0 | Direct |
54826,51604 54826 - Enolase N-terminal domain-like 51604 - Enolase C-terminal domain-like | 0 | Direct |
49417,47719 49417 - p53-like transcription factors 47719 - p53 tetramerization domain | 0 | Direct |
47454,57959 47454 - A DNA-binding domain in eukaryotic transcription factors 57959 - Leucine zipper domain | 0.00004537 | Direct |
82895,82895 82895 - TSP-1 type 1 repeat 82895 - TSP-1 type 1 repeat | 0.00009272 | Direct |
57196,57196 57196 - EGF/Laminin 57196 - EGF/Laminin | 0.0001158 | Direct |
57716,48508 57716 - Glucocorticoid receptor-like (DNA-binding domain) 48508 - Nuclear receptor ligand-binding domain | 0.0007347 | Direct |
54897,52743 54897 - Protease propeptides/inhibitors 52743 - Subtilisin-like | 0.003763 | Inherited |
55785,55785 55785 - PYP-like sensor domain (PAS domain) 55785 - PYP-like sensor domain (PAS domain) | 0.003763 | Inherited |
57184,49899 57184 - Growth factor receptor domain 49899 - Concanavalin A-like lectins/glucanases | 0.003763 | Inherited |
57716,57716 57716 - Glucocorticoid receptor-like (DNA-binding domain) 57716 - Glucocorticoid receptor-like (DNA-binding domain) | 0.007528 | Inherited |
57440,57440 57440 - Kringle-like 57440 - Kringle-like | 0.009971 | Inherited |
57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like | 0.01406 | Inherited |
47459,55785 47459 - HLH, helix-loop-helix DNA-binding domain 55785 - PYP-like sensor domain (PAS domain) | 0.01406 | Inherited |
52743,49785 52743 - Subtilisin-like 49785 - Galactose-binding domain-like | 0.01515 | Inherited |
57440,50494 57440 - Kringle-like 50494 - Trypsin-like serine proteases | 0.03265 | Inherited |
56112,47769 56112 - Protein kinase-like (PK-like) 47769 - SAM/Pointed domain | 0.04272 | Inherited |
52821,52799 52821 - Rhodanese/Cell cycle control phosphatase 52799 - (Phosphotyrosine protein) phosphatases II | 0.04923 | Inherited |
57184,49265 57184 - Growth factor receptor domain 49265 - Fibronectin type III | 0.05647 | Inherited |
57184,57196 57184 - Growth factor receptor domain 57196 - EGF/Laminin | 0.06188 | Inherited |
54452,48726 54452 - MHC antigen-recognition domain 48726 - Immunoglobulin | 0.0685 | Inherited |
47655,49417 47655 - STAT 49417 - p53-like transcription factors | 0.07854 | Inherited |
48092,47655 48092 - Transcription factor STAT-4 N-domain 47655 - STAT | 0.07854 | Inherited |
49417,55550 49417 - p53-like transcription factors 55550 - SH2 domain | 0.07854 | Inherited |
47986,47986 47986 - DEATH domain 47986 - DEATH domain | 0.07854 | Inherited |
55550,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.08021 | Inherited |
81301,81631 81301 - Nucleotidyltransferase 81631 - PAP/OAS1 substrate-binding domain | 0.1147 | Inherited |
56436,57535 56436 - C-type lectin-like 57535 - Complement control module/SCR domain | 0.1164 | Inherited |
53067,100920 53067 - Actin-like ATPase domain 100920 - Heat shock protein 70kD (HSP70), peptide-binding domain | 0.1181 | Inherited |
47986,52129 47986 - DEATH domain 52129 - Caspase-like | 0.1612 | Inherited |
46785,144074 46785 - "Winged helix" DNA-binding domain 144074 - E2F-DP heterodimerization region | 0.2184 | Inherited |
81324,81324 81324 - Voltage-gated potassium channels 81324 - Voltage-gated potassium channels | 0.2439 | Inherited |
52799,52799 52799 - (Phosphotyrosine protein) phosphatases II 52799 - (Phosphotyrosine protein) phosphatases II | 0.2487 | Inherited |
49562,48371 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 48371 - ARM repeat | 0.2906 | Inherited |
50044,55550 50044 - SH3-domain 55550 - SH2 domain | 0.3456 | Inherited |
47954,47954 47954 - Cyclin-like 47954 - Cyclin-like | 0.3994 | Inherited |
90123,52540 90123 - ABC transporter transmembrane region 52540 - P-loop containing nucleoside triphosphate hydrolases | 0.3994 | Inherited |
52833,47616 52833 - Thioredoxin-like 47616 - GST C-terminal domain-like | 0.538 | Inherited |
46579,64593 46579 - Prefoldin 64593 - Intermediate filament protein, coiled coil region | 0.6385 | Inherited |
52540,90123 52540 - P-loop containing nucleoside triphosphate hydrolases 90123 - ABC transporter transmembrane region | 0.735 | Inherited |
63712,90112 63712 - Nicotinic receptor ligand binding domain-like 90112 - Neurotransmitter-gated ion-channel transmembrane pore | 0.8414 | Inherited |
64593,64593 64593 - Intermediate filament protein, coiled coil region 64593 - Intermediate filament protein, coiled coil region | 0.9846 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Triple) in N- to C-terminal order( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
51230,47005,52777 51230 - Single hybrid motif 47005 - Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex 52777 - CoA-dependent acyltransferases | 0 | DIRECT |
48726,82895,82895 48726 - Immunoglobulin 82895 - TSP-1 type 1 repeat 82895 - TSP-1 type 1 repeat | 0 | DIRECT |
57581,57184,57581 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain | 0 | DIRECT |
63737,55486,48371 63737 - Leukotriene A4 hydrolase N-terminal domain 55486 - Metalloproteases ("zincins"), catalytic domain 48371 - ARM repeat | 0 | DIRECT |
57581,57184,57184 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain | 0 | DIRECT |
47473,55550,57850 47473 - EF-hand 55550 - SH2 domain 57850 - RING/U-box | 0 | DIRECT |
57581,57196,57196 57581 - TB module/8-cys domain 57196 - EGF/Laminin 57196 - EGF/Laminin | 0 | DIRECT |
57184,57581,57196 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain 57196 - EGF/Laminin | 0 | DIRECT |
50729,50729,57863 50729 - PH domain-like 50729 - PH domain-like 57863 - ArfGap/RecO-like zinc finger | 0 | DIRECT |
57184,57184,57581 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain | 0 | DIRECT |
57184,57581,57184 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain | 0 | DIRECT |
57196,57581,57184 57196 - EGF/Laminin 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain | 0 | DIRECT |
52540,52540,46785 52540 - P-loop containing nucleoside triphosphate hydrolases 52540 - P-loop containing nucleoside triphosphate hydrolases 46785 - "Winged helix" DNA-binding domain | 0 | DIRECT |
57184,57581,57581 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain 57581 - TB module/8-cys domain | 0 | DIRECT |
47986,47986,52129 47986 - DEATH domain 47986 - DEATH domain 52129 - Caspase-like | 0 | DIRECT |
57440,57440,50494 57440 - Kringle-like 57440 - Kringle-like 50494 - Trypsin-like serine proteases | 0 | DIRECT |
50729,55550,56112 50729 - PH domain-like 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0 | DIRECT |
57924,57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat | 0 | DIRECT |
52540,46785,158702 52540 - P-loop containing nucleoside triphosphate hydrolases 46785 - "Winged helix" DNA-binding domain 158702 - Sec63 N-terminal domain-like | 0 | DIRECT |
53067,53067,53067 53067 - Actin-like ATPase domain 53067 - Actin-like ATPase domain 53067 - Actin-like ATPase domain | 0 | DIRECT |
57196,57196,57581 57196 - EGF/Laminin 57196 - EGF/Laminin 57581 - TB module/8-cys domain | 0 | DIRECT |
100895,47473,57610 100895 - Kazal-type serine protease inhibitors 47473 - EF-hand 57610 - Thyroglobulin type-1 domain | 0 | DIRECT |
48726,48726,82895 48726 - Immunoglobulin 48726 - Immunoglobulin 82895 - TSP-1 type 1 repeat | 0 | DIRECT |
57196,57581,57196 57196 - EGF/Laminin 57581 - TB module/8-cys domain 57196 - EGF/Laminin | 0 | DIRECT |
49562,57889,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain 57889 - Cysteine-rich domain | 0 | DIRECT |
50729,50729,48350 50729 - PH domain-like 50729 - PH domain-like 48350 - GTPase activation domain, GAP | 0 | DIRECT |
55550,56112,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) 56112 - Protein kinase-like (PK-like) | 0 | DIRECT |
49265,49265,53300 49265 - Fibronectin type III 49265 - Fibronectin type III 53300 - vWA-like | 0 | DIRECT |
47668,47473,55550 47668 - N-terminal domain of cbl (N-cbl) 47473 - EF-hand 55550 - SH2 domain | 0 | DIRECT |
57184,57184,57184 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain | 0 | DIRECT |
57196,57196,90193 57196 - EGF/Laminin 57196 - EGF/Laminin 90193 - Notch domain | 0 | DIRECT |
57581,57196,57581 57581 - TB module/8-cys domain 57196 - EGF/Laminin 57581 - TB module/8-cys domain | 0 | DIRECT |
57414,57440,57440 57414 - Hairpin loop containing domain-like 57440 - Kringle-like 57440 - Kringle-like | 0 | DIRECT |
57184,57184,57196 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain 57196 - EGF/Laminin | 0 | DIRECT |
100895,50494,50156 100895 - Kazal-type serine protease inhibitors 50494 - Trypsin-like serine proteases 50156 - PDZ domain-like | 0 | DIRECT |
57196,57184,49899 57196 - EGF/Laminin 57184 - Growth factor receptor domain 49899 - Concanavalin A-like lectins/glucanases | 0 | DIRECT |
57184,100895,50494 57184 - Growth factor receptor domain 100895 - Kazal-type serine protease inhibitors 50494 - Trypsin-like serine proteases | 0 | DIRECT |
57196,57196,69687 57196 - EGF/Laminin 57196 - EGF/Laminin 69687 - Integrin beta tail domain | 0 | DIRECT |
57196,57535,57535 57196 - EGF/Laminin 57535 - Complement control module/SCR domain 57535 - Complement control module/SCR domain | 0 | DIRECT |
82895,82895,82895 82895 - TSP-1 type 1 repeat 82895 - TSP-1 type 1 repeat 82895 - TSP-1 type 1 repeat | 0.0002266 | DIRECT |
57196,57184,57184 57196 - EGF/Laminin 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain | 0.0008869 | DIRECT |
57586,57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like 57586 - TNF receptor-like | 0.007611 | INHERITED FROM: Hydroxybenzoates || propylparaben || Aspirin |
47459,55785,55785 47459 - HLH, helix-loop-helix DNA-binding domain 55785 - PYP-like sensor domain (PAS domain) 55785 - PYP-like sensor domain (PAS domain) | 0.007611 | INHERITED FROM: para-Aminobenzoates || Benzocaine || butamben || Hydroxybenzoates || Aminobenzoates |
54897,52743,49785 54897 - Protease propeptides/inhibitors 52743 - Subtilisin-like 49785 - Galactose-binding domain-like | 0.01515 | INHERITED FROM: Aspirin || Salicylates |
57440,57440,57440 57440 - Kringle-like 57440 - Kringle-like 57440 - Kringle-like | 0.01515 | INHERITED FROM: Hydroxybenzoates || Aspirin || Salicylates |
48092,47655,49417 48092 - Transcription factor STAT-4 N-domain 47655 - STAT 49417 - p53-like transcription factors | 0.07854 | INHERITED FROM: Aspirin || Salicylates |
47655,49417,55550 47655 - STAT 49417 - p53-like transcription factors 55550 - SH2 domain | 0.07854 | INHERITED FROM: Aspirin || Salicylates |
53067,53067,100920 53067 - Actin-like ATPase domain 53067 - Actin-like ATPase domain 100920 - Heat shock protein 70kD (HSP70), peptide-binding domain | 0.1181 | INHERITED FROM: Chloromercuribenzoates |
49562,48371,56112 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 48371 - ARM repeat 56112 - Protein kinase-like (PK-like) | 0.2906 | INHERITED FROM: tamibarotene |
50044,55550,56112 50044 - SH3-domain 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.3083 | INHERITED FROM: Hydroxybenzoates || tamibarotene || Imatinib Mesylate |
90123,52540,90123 90123 - ABC transporter transmembrane region 52540 - P-loop containing nucleoside triphosphate hydrolases 90123 - ABC transporter transmembrane region | 0.735 | INHERITED FROM: Aspirin |
52540,90123,52540 52540 - P-loop containing nucleoside triphosphate hydrolases 90123 - ABC transporter transmembrane region 52540 - P-loop containing nucleoside triphosphate hydrolases | 0.735 | INHERITED FROM: Aspirin |
| Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
51230,47005,52777 51230 - Single hybrid motif 47005 - Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex 52777 - CoA-dependent acyltransferases | 0 | Direct |
48726,82895,82895 48726 - Immunoglobulin 82895 - TSP-1 type 1 repeat 82895 - TSP-1 type 1 repeat | 0 | Direct |
57581,57184,57581 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain | 0 | Direct |
63737,55486,48371 63737 - Leukotriene A4 hydrolase N-terminal domain 55486 - Metalloproteases ("zincins"), catalytic domain 48371 - ARM repeat | 0 | Direct |
57581,57184,57184 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain | 0 | Direct |
47473,55550,57850 47473 - EF-hand 55550 - SH2 domain 57850 - RING/U-box | 0 | Direct |
57581,57196,57196 57581 - TB module/8-cys domain 57196 - EGF/Laminin 57196 - EGF/Laminin | 0 | Direct |
57184,57581,57196 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain 57196 - EGF/Laminin | 0 | Direct |
50729,50729,57863 50729 - PH domain-like 50729 - PH domain-like 57863 - ArfGap/RecO-like zinc finger | 0 | Direct |
57184,57184,57581 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain | 0 | Direct |
57184,57581,57184 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain | 0 | Direct |
57196,57581,57184 57196 - EGF/Laminin 57581 - TB module/8-cys domain 57184 - Growth factor receptor domain | 0 | Direct |
52540,52540,46785 52540 - P-loop containing nucleoside triphosphate hydrolases 52540 - P-loop containing nucleoside triphosphate hydrolases 46785 - "Winged helix" DNA-binding domain | 0 | Direct |
57184,57581,57581 57184 - Growth factor receptor domain 57581 - TB module/8-cys domain 57581 - TB module/8-cys domain | 0 | Direct |
47986,47986,52129 47986 - DEATH domain 47986 - DEATH domain 52129 - Caspase-like | 0 | Direct |
57440,57440,50494 57440 - Kringle-like 57440 - Kringle-like 50494 - Trypsin-like serine proteases | 0 | Direct |
50729,55550,56112 50729 - PH domain-like 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0 | Direct |
57924,57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat | 0 | Direct |
52540,46785,158702 52540 - P-loop containing nucleoside triphosphate hydrolases 46785 - "Winged helix" DNA-binding domain 158702 - Sec63 N-terminal domain-like | 0 | Direct |
53067,53067,53067 53067 - Actin-like ATPase domain 53067 - Actin-like ATPase domain 53067 - Actin-like ATPase domain | 0 | Direct |
57196,57196,57581 57196 - EGF/Laminin 57196 - EGF/Laminin 57581 - TB module/8-cys domain | 0 | Direct |
100895,47473,57610 100895 - Kazal-type serine protease inhibitors 47473 - EF-hand 57610 - Thyroglobulin type-1 domain | 0 | Direct |
48726,48726,82895 48726 - Immunoglobulin 48726 - Immunoglobulin 82895 - TSP-1 type 1 repeat | 0 | Direct |
57196,57581,57196 57196 - EGF/Laminin 57581 - TB module/8-cys domain 57196 - EGF/Laminin | 0 | Direct |
49562,57889,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain 57889 - Cysteine-rich domain | 0 | Direct |
50729,50729,48350 50729 - PH domain-like 50729 - PH domain-like 48350 - GTPase activation domain, GAP | 0 | Direct |
55550,56112,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) 56112 - Protein kinase-like (PK-like) | 0 | Direct |
49265,49265,53300 49265 - Fibronectin type III 49265 - Fibronectin type III 53300 - vWA-like | 0 | Direct |
47668,47473,55550 47668 - N-terminal domain of cbl (N-cbl) 47473 - EF-hand 55550 - SH2 domain | 0 | Direct |
57184,57184,57184 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain | 0 | Direct |
57196,57196,90193 57196 - EGF/Laminin 57196 - EGF/Laminin 90193 - Notch domain | 0 | Direct |
57581,57196,57581 57581 - TB module/8-cys domain 57196 - EGF/Laminin 57581 - TB module/8-cys domain | 0 | Direct |
57414,57440,57440 57414 - Hairpin loop containing domain-like 57440 - Kringle-like 57440 - Kringle-like | 0 | Direct |
57184,57184,57196 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain 57196 - EGF/Laminin | 0 | Direct |
100895,50494,50156 100895 - Kazal-type serine protease inhibitors 50494 - Trypsin-like serine proteases 50156 - PDZ domain-like | 0 | Direct |
57196,57184,49899 57196 - EGF/Laminin 57184 - Growth factor receptor domain 49899 - Concanavalin A-like lectins/glucanases | 0 | Direct |
57184,100895,50494 57184 - Growth factor receptor domain 100895 - Kazal-type serine protease inhibitors 50494 - Trypsin-like serine proteases | 0 | Direct |
57196,57196,69687 57196 - EGF/Laminin 57196 - EGF/Laminin 69687 - Integrin beta tail domain | 0 | Direct |
57196,57535,57535 57196 - EGF/Laminin 57535 - Complement control module/SCR domain 57535 - Complement control module/SCR domain | 0 | Direct |
82895,82895,82895 82895 - TSP-1 type 1 repeat 82895 - TSP-1 type 1 repeat 82895 - TSP-1 type 1 repeat | 0.0002266 | Direct |
57196,57184,57184 57196 - EGF/Laminin 57184 - Growth factor receptor domain 57184 - Growth factor receptor domain | 0.0008869 | Direct |
57586,57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like 57586 - TNF receptor-like | 0.007611 | Inherited |
47459,55785,55785 47459 - HLH, helix-loop-helix DNA-binding domain 55785 - PYP-like sensor domain (PAS domain) 55785 - PYP-like sensor domain (PAS domain) | 0.007611 | Inherited |
54897,52743,49785 54897 - Protease propeptides/inhibitors 52743 - Subtilisin-like 49785 - Galactose-binding domain-like | 0.01515 | Inherited |
57440,57440,57440 57440 - Kringle-like 57440 - Kringle-like 57440 - Kringle-like | 0.01515 | Inherited |
48092,47655,49417 48092 - Transcription factor STAT-4 N-domain 47655 - STAT 49417 - p53-like transcription factors | 0.07854 | Inherited |
47655,49417,55550 47655 - STAT 49417 - p53-like transcription factors 55550 - SH2 domain | 0.07854 | Inherited |
53067,53067,100920 53067 - Actin-like ATPase domain 53067 - Actin-like ATPase domain 100920 - Heat shock protein 70kD (HSP70), peptide-binding domain | 0.1181 | Inherited |
49562,48371,56112 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 48371 - ARM repeat 56112 - Protein kinase-like (PK-like) | 0.2906 | Inherited |
50044,55550,56112 50044 - SH3-domain 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.3083 | Inherited |
90123,52540,90123 90123 - ABC transporter transmembrane region 52540 - P-loop containing nucleoside triphosphate hydrolases 90123 - ABC transporter transmembrane region | 0.735 | Inherited |
52540,90123,52540 52540 - P-loop containing nucleoside triphosphate hydrolases 90123 - ABC transporter transmembrane region 52540 - P-loop containing nucleoside triphosphate hydrolases | 0.735 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Plot distribution on species Tree Of Life (sTOL) for Superfamily and/or Family domains annotated by this CC term
 |
Plot tree as:
| |
Download Newick format tree:
|
( show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domain
architecture data for all genomes in SUPERFAMILY. The PAUP
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
Plot distribution on species Tree Of Life (sTOL) for single supra-domains annotated by this CC term
 |
Plot tree as:
| |
Download Newick format tree:
| |
Browsing in TREE OF LIFE:
|
( show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domains and supradomains
for all genomes in SUPERFAMILY. The RAxML
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
|
  
|